Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2005);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Region;Publisher;Coverage;Categories
1;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;10.789;Q1;210;29;71;4036;1657;71;22.54;139.17;United States;Northern America;Annual Reviews Inc.;1965-1973, 1975-2021;"Pharmacology (Q1); Toxicology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;9.872;Q1;241;30;73;5479;1692;71;16.14;182.63;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1949, 1951-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;20425;Nature Reviews Drug Discovery;journal;14741784, 14741776;7.654;Q1;348;339;809;8032;5044;255;5.57;23.69;United Kingdom;Western Europe;Nature Publishing Group;2002-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
4;24032;Reviews of Physiology Biochemistry and Pharmacology;journal;16175786, 03034240;5.545;Q1;66;10;40;2129;396;40;10.21;212.9;Germany;Western Europe;Springer Verlag;1974-2008, 2012-2018;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;18733735, 01656147;4.267;Q1;225;106;404;5469;3333;340;9.1;51.59;United Kingdom;Western Europe;Elsevier Ltd.;1979-2021;"Pharmacology (Q1); Toxicology (Q1)"
6;21195;Pharmacology and Therapeutics;journal;1879016X, 01637258;3.888;Q1;211;85;183;14160;1736;180;9.33;166.59;United States;Northern America;Elsevier Inc.;1975-1977, 1979-1985, 1987-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
7;26371;Natural Product Reports;journal;02650568, 14604752;3.169;Q1;188;39;132;6176;988;128;6.7;158.36;United Kingdom;Western Europe;Royal Society of Chemistry;1984-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
8;19907;Medicinal Research Reviews;journal;01986325, 10981128;2.935;Q1;134;29;80;3798;787;80;9.22;130.97;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
9;19409;Advanced Drug Delivery Reviews;journal;0169409X, 18728294;2.713;Q1;331;145;336;13073;3138;286;7.55;90.16;Netherlands;Western Europe;Elsevier;1987-2021;Pharmaceutical Science (Q1)
10;12611;Drug Resistance Updates;journal;13687646, 15322084;2.708;Q1;119;29;87;3075;602;82;6.78;106.03;United States;Northern America;Churchill Livingstone;1998-2021;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
11;21100456838;Cell Chemical Biology;journal;24519448, 24519456;2.694;Q1;190;176;551;6110;2820;522;4.82;34.72;United States;Northern America;Elsevier Inc.;2016-2021;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
12;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;2.691;Q1;233;271;707;24423;3740;702;4.91;90.12;Switzerland;Western Europe;Birkhauser Verlag Basel;1952, 1997-2021;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
13;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.679;Q1;202;440;1035;16876;5821;1034;5.48;38.35;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1965-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
14;18017;Neuropsychopharmacology;journal;0893133X, 1470634X;2.583;Q1;227;238;727;13808;4196;688;5.5;58.02;United Kingdom;Western Europe;Nature Publishing Group;1987-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
15;20626;Clinical Pharmacology and Therapeutics;journal;15326535, 00099236;2.562;Q1;195;138;425;4914;2796;341;6.52;35.61;United States;Northern America;Wiley-Blackwell;1960-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
16;20681;Current Opinion in Pharmacology;journal;14714973, 14714892;2.367;Q1;139;100;315;4607;1736;283;5.82;46.07;Netherlands;Western Europe;Elsevier BV;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
17;29311;Current Cancer Drug Targets;journal;15680096, 18735576;2.351;Q1;96;49;112;6470;633;109;5.8;132.04;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Cancer Research (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
18;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.335;Q1;146;116;305;5976;1353;283;4.62;51.52;Germany;Western Europe;Springer Verlag;1976-1978, 1980-1981, 1995-2021;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
19;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;2.324;Q1;115;132;209;6586;1076;207;4.91;49.89;Netherlands;Western Europe;Springer Netherlands;1996-2021;"Biochemistry (medical) (Q1); Cancer Research (Q1); Cell Biology (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
20;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.321;Q1;269;878;2237;25709;11408;2153;4.96;29.28;United States;Northern America;American Society for Microbiology;1963-1970, 1972-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
21;130044;Pharmacogenetics and Genomics;journal;17446880, 17446872;2.201;-;144;105;299;3713;1939;286;6.03;35.36;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2005-2021;"Genetics (Q1); Genetics (clinical) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1)"
22;21000196010;Topics in antiviral medicine;journal;21615861, 21615853;2.179;Q1;43;19;44;164;190;44;4.32;8.63;United States;Northern America;International Antiviral Society;2011-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q1)"
23;18148;Pain;journal;18726623, 03043959;2.16;Q1;269;358;910;14240;4794;822;4.95;39.78;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1975-2021;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
24;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;2.095;Q1;90;63;126;9179;719;123;4.96;145.7;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology (Q1)"
25;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;2.061;Q1;76;72;149;2911;711;145;2.51;40.43;United States;Northern America;Elsevier Inc.;1996, 1998-2021;"Biochemistry (Q1); Pharmacology (Q1); Physiology (Q1); Cell Biology (Q2)"
26;12455;Molecular Therapy;journal;15250024, 15250016;2.054;Q1;185;244;707;9952;3606;615;5.06;40.79;United States;Northern America;Cell Press;2000-2021;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
27;20435;Neuropharmacology;journal;00283908, 18737064;2.034;Q1;176;250;728;11590;3093;727;4.05;46.36;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;"Cellular and Molecular Neuroscience (Q1); Pharmacology (Q1)"
28;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;1.941;Q1;276;873;1969;36843;10873;1969;5.49;42.2;United States;Northern America;American Chemical Society;1959-1961, 1963-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
29;20663;Current Drug Metabolism;journal;18755453, 13892002;1.926;Q1;111;42;120;4777;770;114;6.12;113.74;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1)"
30;145164;Human Genomics;journal;14739542, 14797364;1.921;Q1;59;22;43;868;116;42;2.7;39.45;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2006, 2008-2021;"Drug Discovery (Q1); Genetics (Q1); Molecular Medicine (Q1); Molecular Biology (Q2)"
31;21782;Psychopharmacology;journal;00333158, 14322072;1.898;Q1;202;461;1031;23539;4572;978;4.43;51.06;Germany;Western Europe;Springer Verlag;1959-2021;Pharmacology (Q1)
32;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.85;Q1;117;36;49;3985;291;47;5.36;110.69;United Kingdom;Western Europe;Informa Healthcare;1971-2021;Toxicology (Q1)
33;26380;Drug and Alcohol Dependence;journal;03768716;1.799;Q1;173;160;432;6632;1721;422;3.46;41.45;Ireland;Western Europe;Elsevier Ireland Ltd;1975-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
34;12331;Current Topics in Medicinal Chemistry;journal;15680266, 18734294;1.796;Q1;122;132;319;10394;1667;297;4.59;78.74;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
35;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;1.768;Q1;203;444;1354;11452;5470;1138;4.04;25.79;United Kingdom;Western Europe;Oxford University Press;1975-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
36;20624;Clinical Pharmacokinetics;journal;11791926, 03125963;1.745;Q1;169;86;248;6300;1682;245;6.97;73.26;United Kingdom;Western Europe;Adis International Ltd;1976-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
37;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.745;Q1;233;640;1825;24003;8815;1824;4.6;37.5;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1945-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
38;23488;Current Medicinal Chemistry;journal;09298673, 1875533X;1.709;Q1;183;184;560;24924;2827;526;5.16;135.46;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1994-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
39;21790;Antiviral Therapy;journal;20402058, 13596535;1.694;Q1;89;127;241;4818;923;229;4.09;37.94;United Kingdom;Western Europe;International Medical Press Ltd;1996-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
40;16876;Bioconjugate Chemistry;journal;15204812, 10431802;1.691;Q1;177;207;525;7461;2516;521;4.48;36.04;United States;Northern America;American Chemical Society;1990-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
41;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.669;Q1;182;258;652;8540;3102;641;4.51;33.1;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1973-2021;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
42;20682;Current Pharmaceutical Design;journal;13816128, 18734286;1.647;Q1;166;314;799;38219;3817;697;4.87;121.72;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1995-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
43;20063;Biochemical Pharmacology;journal;18732968, 00062952;1.6;Q1;206;401;1391;17186;5751;1338;4.06;42.86;United States;Northern America;Elsevier Inc.;1958-2021;"Biochemistry (Q1); Pharmacology (Q1)"
44;23010;Journal of Controlled Release;journal;18734995, 01683659;1.57;Q1;282;430;801;13738;3938;798;4.53;31.95;Netherlands;Western Europe;Elsevier;1984-2021;Pharmaceutical Science (Q1)
45;28792;Cancer Biology and Therapy;journal;15384047, 15558576;1.562;Q1;120;350;596;8579;1304;396;2.1;24.51;United States;Northern America;Landes Bioscience;2002-2021;"Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1); Cancer Research (Q2)"
46;20084;British Journal of Pharmacology;journal;14765381, 00071188;1.559;Q1;223;384;1487;16013;5523;1443;3.59;41.7;United States;Northern America;Wiley-Blackwell;1965-2021;Pharmacology (Q1)
47;23916;Environmental Pollution;journal;02697491, 18736424;1.51;Q1;249;327;870;13369;2491;863;2.76;40.88;United Kingdom;Western Europe;Elsevier Ltd.;1970-1980, 1986-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
48;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863, 2162660X;1.464;Q1;76;11;40;2379;226;40;4.8;216.27;United States;Northern America;Begell House Inc.;1984-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
49;20664;Current Drug Targets;journal;18735592, 13894501;1.451;Q1;107;92;172;9901;728;160;4.4;107.62;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
50;29682;Receptors and Channels;journal;10606823;1.445;Q1;42;0;90;0;260;85;2.19;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2004;"Clinical Biochemistry (Q1); Endocrinology (Q1); Pharmacology (Q1); Cell Biology (Q2)"
51;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;1.425;Q1;100;47;129;5410;526;122;3.36;115.11;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
52;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.395;Q1;90;45;176;1837;688;149;3.66;40.82;United Kingdom;Western Europe;Nature Publishing Group;2001-2021;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
53;25125;Journal of Analytical Toxicology;journal;19452403, 01464760;1.389;Q1;78;129;317;2652;638;300;1.85;20.56;United States;Northern America;Preston Publications;1977-2021;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Environmental Chemistry (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
54;26795;Controlled Clinical Trials;journal;01972456;1.383;Q1;74;0;186;0;437;162;2.32;0;Netherlands;Western Europe;Elsevier BV;1980-2004;Pharmacology (Q1)
55;26512;Tetrahedron;journal;14645416, 00404020;1.375;Q1;226;1219;3383;54820;9954;3365;2.87;44.97;United Kingdom;Western Europe;Elsevier Ltd.;1957-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
56;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.368;Q1;70;28;121;875;484;114;3.99;31.25;United States;Northern America;Mary Ann Liebert Inc.;2011-2021;"Drug Discovery (Q1); Biochemistry (Q2); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
57;19034;Microbial Drug Resistance;journal;10766294, 19318448;1.364;Q1;72;58;165;1631;470;165;2.67;28.12;United States;Northern America;Mary Ann Liebert Inc.;1995-2021;"Medicine (miscellaneous) (Q1); Microbiology (medical) (Q1); Pharmacology (Q1); Immunology (Q2); Microbiology (Q2)"
58;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.337;Q1;113;73;175;2974;611;152;3.21;40.74;United Kingdom;Western Europe;Oxford University Press;1998-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
59;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.295;Q1;129;128;318;4646;1008;312;1.94;36.3;United States;Northern America;Alcohol Research Documentation, Inc.;2007-2021;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
60;110112;Journal of Immunotherapy;journal;15249557, 15374513;1.287;Q1;97;70;126;2739;481;121;3.93;39.13;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2021;"Immunology and Allergy (Q1); Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2)"
61;20677;Current Opinion in Drug Discovery and Development;journal;13676733;1.278;Q1;81;73;265;3560;1016;250;4.16;48.77;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
62;25218;Toxicological Sciences;journal;10960929, 10966080;1.276;Q1;193;320;831;14102;3069;796;3.2;44.07;United Kingdom;Western Europe;Oxford University Press;1981-2021;Toxicology (Q1)
63;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.273;Q1;163;222;583;9931;2069;580;3.58;44.73;United States;Northern America;American Chemical Society;1988-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
64;23053;Journal of Natural Products;journal;01633864, 15206025;1.272;Q1;147;385;1241;9016;3339;1235;2.69;23.42;United States;Northern America;American Chemical Society;1949, 1971, 1973, 1978-2021;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
65;20758;Current Drug Targets: Inflammation and Allergy;journal;1568010X;1.265;Q1;51;88;110;9313;356;106;2.71;105.83;Netherlands;Western Europe;Bentham Science Publishers B.V.;2002-2005;"Immunology and Allergy (Q1); Pharmacology (Q1); Immunology (Q2)"
66;20049;Behavioural Pharmacology;journal;14735849, 09558810;1.26;Q1;83;76;208;3699;604;194;2.62;48.67;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1992-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
67;26514;Tetrahedron Letters;journal;00404039, 18733581;1.26;Q1;173;1944;6490;54880;17379;6489;2.74;28.23;United Kingdom;Western Europe;Elsevier Ltd.;1959-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
68;19617;Antiviral Research;journal;01663542, 18729096;1.233;Q1;134;75;279;2850;1105;277;3.95;38;Netherlands;Western Europe;Elsevier;1959, 1981-2021;"Pharmacology (Q1); Virology (Q2)"
69;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.233;Q1;213;239;832;8440;2882;827;3.22;35.31;United States;Northern America;Springer New York;1984-2021;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
70;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.208;Q1;175;353;646;16203;2357;633;3.56;45.9;United States;Northern America;Academic Press Inc.;1959-2021;"Pharmacology (Q1); Toxicology (Q1)"
71;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.191;Q1;100;21;101;4103;458;99;4.09;195.38;United States;Northern America;Informa Healthcare;1972-2021;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
72;22378;Vascular Pharmacology;journal;18793649, 15371891;1.188;Q1;100;85;159;3817;493;154;1.11;44.91;United States;Northern America;Elsevier Inc.;2002-2021;"Pharmacology (Q1); Molecular Medicine (Q2); Physiology (Q2)"
73;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.185;Q1;96;58;167;1793;380;165;2.03;30.91;United Kingdom;Western Europe;Nature Publishing Group;2006-2021;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
74;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.163;Q1;159;296;819;13926;2447;814;2.8;47.05;United States;Northern America;Wiley-Blackwell;1977-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
75;18922;Journal of Gene Medicine;journal;1099498X, 15212254;1.158;Q1;94;149;341;6447;1393;334;4.26;43.27;United States;Northern America;John Wiley and Sons Ltd;1998-2021;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
76;29712;Clinical Therapeutics;journal;1879114X, 01492918;1.136;Q1;140;194;597;7652;2201;523;3.71;39.44;United States;Northern America;Elsevier Inc.;1977-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
77;15581;Current Pharmaceutical Biotechnology;journal;13892010, 18734316;1.131;Q1;88;44;127;3041;406;114;2.76;69.11;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Biotechnology (Q1); Pharmaceutical Science (Q1)"
78;20680;Current Opinion in Molecular Therapeutics;journal;14648431;1.121;Q1;66;82;268;4057;785;242;2.82;49.48;United Kingdom;Western Europe;Current Drugs Ltd.;1999-2010;"Drug Discovery (Q1); Pharmacology (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
79;21687;American Journal of PharmacoGenomics;journal;11752203;1.106;Q1;38;37;103;3255;343;102;3.55;87.97;United Kingdom;Western Europe;Adis International Ltd;2001-2005;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
80;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;18733441, 09396411;1.083;Q1;168;137;336;4553;1020;331;3.03;33.23;Netherlands;Western Europe;Elsevier;1991-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
81;22072;Current Gene Therapy;journal;18755631, 15665232;1.077;Q1;75;58;114;6023;464;112;3.63;103.84;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
82;110172;Progress in Drug Research;book series;0071786X;1.063;Q1;44;23;39;2369;120;35;2.64;103;Switzerland;Western Europe;Birkhauser Verlag Basel;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
83;14144;Experimental and Clinical Psychopharmacology;journal;19362293, 10641297;1.061;Q1;95;40;123;1888;273;123;2.09;47.2;United States;Northern America;American Psychological Association;1993-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
84;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;1.06;Q1;21;7;14;365;28;13;2;52.14;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2011;"Pharmacology (Q1); Immunology (Q2)"
85;21351;Expert Opinion on Investigational Drugs;journal;13543784, 17447658;1.059;Q1;109;137;423;11445;1577;412;3.59;83.54;United Kingdom;Western Europe;Taylor and Francis Ltd.;1994-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
86;21237;Drug Safety;journal;01145916, 11791942;1.053;Q1;131;86;272;5982;1145;258;4.05;69.56;United Kingdom;Western Europe;Adis International Ltd;1990-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
87;21455;Progress in Medicinal Chemistry;journal;00796468, 18757863;1.045;Q1;36;8;26;868;79;22;2.6;108.5;Netherlands;Western Europe;Elsevier;1961-1963, 1965, 1967, 1969-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
88;22454;International Journal of Pharmaceutics;journal;18733476, 03785173;1.043;Q1;229;450;1283;11834;3777;1276;2.7;26.3;Netherlands;Western Europe;Elsevier;1978-2021;Pharmaceutical Science (Q1)
89;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;18784216, 02785846;1.04;Q1;134;167;504;8284;1482;498;3.36;49.6;United States;Northern America;Elsevier Inc.;1982-2022;"Pharmacology (Q1); Biological Psychiatry (Q2)"
90;23079;Journal of Pharmaceutical Sciences;journal;15206017, 00223549;1.039;Q1;186;250;793;8561;2178;781;2.74;34.24;United States;Northern America;"John Wiley &amp; Sons Inc.";1961-2021;Pharmaceutical Science (Q1)
91;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.038;Q1;153;208;623;4715;1919;526;2.91;22.67;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
92;21197;Pharmacology Biochemistry and Behavior;journal;00913057, 18735177;1.03;Q1;139;274;890;14027;2404;883;2.18;51.19;United States;Northern America;Elsevier Inc.;1973-2021;"Pharmacology (Q1); Toxicology (Q1); Biochemistry (Q2); Biological Psychiatry (Q2); Clinical Biochemistry (Q2); Behavioral Neuroscience (Q3)"
93;21333;European Journal of Pharmacology;journal;00142999, 18790712;1.022;Q1;189;617;2269;23689;6616;2258;2.83;38.39;Netherlands;Western Europe;Elsevier;1967-2021;Pharmacology (Q1)
94;25219;Toxicology;journal;0300483X, 18793185;1.018;Q1;165;319;825;13669;2708;813;2.88;42.85;Ireland;Western Europe;Elsevier Ireland Ltd;1959, 1973-2021;Toxicology (Q1)
95;15576;European Neuropsychopharmacology;journal;0924977X, 18737862;1.011;Q1;118;83;262;3668;757;261;2.89;44.19;Netherlands;Western Europe;Elsevier;1990-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Neurology (Q2); Biological Psychiatry (Q3)"
96;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085, 1873264X;1.009;Q1;133;477;1350;11011;3025;1347;2.18;23.08;Netherlands;Western Europe;Elsevier;1983-2022;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Spectroscopy (Q2)"
97;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.009;Q1;89;12;40;1342;140;39;3.39;111.83;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
98;18073;NeuroToxicology;journal;18729711, 0161813X;1.006;Q1;122;100;261;4732;796;258;2.74;47.32;Netherlands;Western Europe;Elsevier;1979-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
99;25240;Toxicology Letters;journal;03784274, 18793169;1.006;Q1;150;175;851;5961;2529;825;2.77;34.06;Netherlands;Western Europe;Elsevier BV;1977-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
100;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;1.005;Q1;115;122;409;4392;785;408;1.54;36;United States;Northern America;Springer New York;1973-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
101;25075;Ecotoxicology;journal;09639292, 15733017;1.003;Q1;97;67;161;3058;282;150;1.67;45.64;Netherlands;Western Europe;Springer Netherlands;1992-2021;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
102;21354;Expert Opinion on Therapeutic Targets;journal;14728222, 17447631;0.999;Q1;94;89;169;10586;416;159;2.61;118.94;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2021;"Drug Discovery (Q1); Pharmacology (Q1); Clinical Biochemistry (Q2); Molecular Medicine (Q2)"
103;22983;Journal of Clinical Pharmacology;journal;15524604, 00912700;0.998;Q1;121;151;443;4500;1614;440;3.75;29.8;United States;Northern America;Wiley-Blackwell;1973-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
104;22477;Investigational New Drugs;journal;01676997, 15730646;0.997;Q1;90;68;149;1989;427;147;2.97;29.25;Netherlands;Western Europe;Kluwer Academic Publishers;1983-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Oncology (Q2)"
105;24763;Addictive Behaviors;journal;03064603;0.994;Q1;135;183;403;4416;868;402;1.89;24.13;United Kingdom;Western Europe;Elsevier Ltd.;1975-2022;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
106;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.992;Q1;55;31;94;4786;277;87;2.64;154.39;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Microbiology (medical) (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
107;17595;Journal of Biomolecular Screening;journal;10870571, 1552454X;0.983;Q1;79;82;192;2378;620;188;3.32;29;United States;Northern America;SAGE Publications Inc.;1996-2017;"Drug Discovery (Q1); Pharmacology (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Biotechnology (Q2); Molecular Medicine (Q3)"
108;24786;Alcohol and Alcoholism;journal;07350414, 14643502;0.977;Q1;103;92;294;3350;782;279;2.24;36.41;United Kingdom;Western Europe;Oxford University Press;1965-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
109;18075;Neurotoxicology and Teratology;journal;08920362, 18729738;0.975;Q1;103;79;227;3905;616;210;2.33;49.43;United States;Northern America;Elsevier Inc.;1987-2021;"Toxicology (Q1); Developmental Neuroscience (Q2); Cellular and Molecular Neuroscience (Q3)"
110;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;0.974;Q1;154;1063;2914;25485;7745;2910;2.8;23.97;United Kingdom;Western Europe;Elsevier Ltd.;1991-2021;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Organic Chemistry (Q2); Molecular Biology (Q3); Molecular Medicine (Q3)"
111;23109;Journal of Psychopharmacology;journal;14617285, 02698811;0.956;Q1;121;120;218;4648;617;194;2.95;38.73;United Kingdom;Western Europe;SAGE Publications Ltd;1987-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
112;24652;Chemico-Biological Interactions;journal;00092797;0.951;Q1;128;195;286;5161;857;281;2.28;26.47;Ireland;Western Europe;Elsevier Ireland Ltd;1969-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
113;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.95;Q1;96;137;346;4114;1144;331;3.11;30.03;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
114;13250;Expert Opinion on Biological Therapy;journal;14712598, 17447682;0.943;Q1;91;140;378;11936;1051;365;2.87;85.26;United Kingdom;Western Europe;Taylor and Francis Ltd.;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1); Clinical Biochemistry (Q2)"
115;21331;European Journal of Pharmaceutical Sciences;journal;18790720, 09280987;0.938;Q1;144;279;409;5431;1223;402;2.75;19.47;Netherlands;Western Europe;Elsevier;1993-2021;Pharmaceutical Science (Q1)
116;25151;Journal of Toxicology and Environmental Health - Part A: Current Issues;journal;10872620, 15287394;0.931;Q1;92;151;404;5652;970;393;2.16;37.43;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
117;14805;Steroids;journal;0039128X, 18785867;0.928;Q2;107;119;371;4026;1041;369;2.57;33.83;United States;Northern America;Elsevier Inc.;1963-2021;"Biochemistry (Q2); Clinical Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3)"
118;20679;Current Opinion in Investigational Drugs;journal;20403429, 14724472;0.921;Q2;79;148;571;8853;1609;531;3.05;59.82;United Kingdom;Western Europe;Current Drugs Ltd.;2000-2010;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
119;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.915;Q2;85;265;945;9919;1837;945;1.81;37.43;United States;Northern America;Wiley-Blackwell;1918-2021;"Biochemistry (Q2); Drug Discovery (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3)"
120;16948;Chirality;journal;1520636X, 08990042;0.907;Q2;80;116;350;3566;721;345;2.09;30.74;United States;Northern America;Wiley-Liss Inc.;1989-2021;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
121;21841;Food Additives and Contaminants;journal;0265203X, 14645122;0.907;Q2;102;165;435;4630;922;428;1.81;28.06;United Kingdom;Western Europe;Taylor and Francis Ltd.;1984-2008;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Public Health, Environmental and Occupational Health (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
122;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;0.904;Q2;104;63;191;2725;633;191;2.37;43.25;Netherlands;Western Europe;Springer Netherlands;1987-2021;"Computer Science Applications (Q1); Drug Discovery (Q2); Physical and Theoretical Chemistry (Q2)"
123;21165;PharmacoEconomics;journal;11707690, 11792027;0.904;Q2;104;110;331;4430;904;312;2.63;40.27;United Kingdom;Western Europe;Adis International Ltd;1992-2021;"Health Policy (Q1); Public Health, Environmental and Occupational Health (Q1); Pharmacology (Q2)"
124;25096;Food and Chemical Toxicology;journal;18736351, 02786915;0.897;Q2;183;161;578;7361;1596;564;2.41;45.72;United Kingdom;Western Europe;Elsevier Ltd.;1982-2021;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2)"
125;25109;Inhalation Toxicology;journal;08958378, 10917691;0.895;Q2;90;76;256;3304;625;252;2.39;43.47;United Kingdom;Western Europe;Informa Healthcare;1989-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
126;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;0.894;Q1;171;661;1592;23374;3996;1589;2.46;35.36;United Kingdom;Western Europe;Elsevier Ltd.;1993-2021;"Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3); Molecular Medicine (Q3)"
127;20473;Life Sciences;journal;18790631, 00243205;0.894;Q1;174;530;1659;20367;4571;1658;2.83;38.43;United States;Northern America;Elsevier Inc.;1962-2021;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2)"
128;19984;Assay and Drug Development Technologies;journal;1540658X, 15578127;0.89;Q2;58;51;144;1528;329;136;2.2;29.96;United States;Northern America;Mary Ann Liebert Inc.;2002-2021;"Drug Discovery (Q2); Molecular Medicine (Q3)"
129;21167;Pharmacogenomics;journal;14622416, 17448042;0.886;Q2;94;89;277;4121;774;240;2.64;46.3;United Kingdom;Western Europe;Future Medicine Ltd.;2000-2021;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
130;29097;Cancer Chemotherapy and Pharmacology;journal;14320843, 03445704;0.877;Q2;114;175;455;5518;1149;455;2.43;31.53;Germany;Western Europe;Springer Verlag;1978-2021;"Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2); Pharmacology (Q2); Toxicology (Q2)"
131;23155;Current Vascular Pharmacology;journal;15701611, 18756212;0.869;Q2;63;42;70;4147;156;70;2.23;98.74;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2003-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2)"
132;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;0.862;Q2;114;166;420;3953;1079;390;2.63;23.81;Germany;Western Europe;Springer Verlag;1968-2021;"Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
133;21744;Planta Medica;journal;14390221, 00320943;0.856;Q1;122;242;825;4613;1703;821;1.94;19.06;Germany;Western Europe;Georg Thieme Verlag;1961, 1965-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
134;22319;Toxicon;journal;18793150, 00410101;0.844;Q2;133;244;661;9016;1579;651;2.28;36.95;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;Toxicology (Q2)
135;18005;American Journal of Respiratory Medicine;journal;11756365;0.841;Q2;32;0;93;0;266;87;3.5;0;United Kingdom;Western Europe;Adis International Ltd;2002-2003;"Pulmonary and Respiratory Medicine (Q1); Pharmacology (Q2)"
136;22575;Cardiovascular Toxicology;journal;15307905, 15590259;0.829;Q2;56;33;89;1940;213;85;2.45;58.79;United States;Northern America;Humana Press;2001-2021;"Cardiology and Cardiovascular Medicine (Q1); Toxicology (Q2); Molecular Biology (Q3)"
137;24797;Mini-Reviews in Medicinal Chemistry;journal;18755607, 13895575;0.828;Q2;95;99;224;8937;619;215;2.77;90.27;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
138;21196;Drug Discovery Today;journal;18785832, 13596446;0.823;Q2;185;320;839;9453;2277;632;2.71;29.54;United Kingdom;Western Europe;Elsevier Ltd.;1996-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
139;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412703, 19412711;0.82;Q1;73;34;120;1171;289;115;2.3;34.44;United States;Northern America;Mary Ann Liebert Inc.;2008-2021;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q1); Pulmonary and Respiratory Medicine (Q1)"
140;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073, 18755402;0.814;Q2;66;88;219;4264;575;203;2.62;48.45;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1998-2021;"Computer Science Applications (Q1); Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2)"
141;21169;Pharmacological Research;journal;10436618, 10961186;0.805;Q2;147;141;472;6058;1200;468;2.69;42.96;United States;Northern America;Academic Press Inc.;1989-2021;Pharmacology (Q2)
142;20783;Expert Review of Vaccines;journal;14760584, 17448395;0.801;Q2;91;82;240;5937;565;220;2.47;72.4;United Kingdom;Western Europe;Taylor and Francis Ltd.;2002-2021;"Drug Discovery (Q2); Pharmacology (Q2); Immunology (Q3); Molecular Medicine (Q3)"
143;23015;Journal of Ethnopharmacology;journal;03788741, 18727573;0.794;Q2;205;453;805;13699;1920;799;1.98;30.24;Ireland;Western Europe;Elsevier Ireland Ltd;1979-2022;"Drug Discovery (Q2); Pharmacology (Q2)"
144;20104;CNS Drug Reviews;journal;1080563X, 15273458;0.791;Q2;61;27;71;1777;205;69;3.11;65.81;United States;Northern America;Neva Press, Inc.;1995-2007;"Neuropsychology and Physiological Psychology (Q2); Pharmacology (Q2)"
145;22432;International Immunopharmacology;journal;18781705, 15675769;0.784;Q2;119;191;535;7307;1329;531;2.26;38.26;Netherlands;Western Europe;Elsevier;2001-2021;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
146;15840;Journal of Antibiotics;journal;00218820, 18811469;0.784;Q2;84;107;402;1781;601;344;1.54;16.64;United Kingdom;Western Europe;Japan Antibiotics Research Association;1953-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
147;4000150314;Chemical Biology and Drug Design;journal;17470277;0.78;-;82;128;214;4228;398;213;1.75;33.03;United Kingdom;Western Europe;Blackwell;2006-2021;"Biochemistry (Q3); Molecular Medicine (Q3)"
148;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484, 19404034;0.777;Q2;52;43;130;1472;251;117;1.84;34.23;United Kingdom;Western Europe;SAGE Publications Ltd;1996-2021;"Pharmacology (medical) (Q1); Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
149;27823;Alimentary Pharmacology and Therapeutics, Supplement;journal;09530673;0.774;Q1;66;67;260;1779;632;256;2.23;26.55;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1991, 1993-2005;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
150;18071;Neurotoxicity Research;journal;14763524, 10298428;0.772;Q2;78;52;181;4834;389;177;2.12;92.96;United States;Northern America;Springer New York;1999, 2001-2021;"Neuroscience (miscellaneous) (Q2); Toxicology (Q2)"
151;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.765;Q2;109;158;407;5443;955;347;2.47;34.45;France;Western Europe;Elsevier Masson s.r.l.;1982-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
152;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.762;Q2;96;146;402;5405;933;399;2.12;37.02;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1990-2021;"Pharmacology (medical) (Q1); Oncology (Q2); Pharmacology (Q2); Cancer Research (Q3)"
153;9000153111;Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology;journal;15320456, 18781659;0.754;Q2;113;93;429;4037;915;426;1.68;43.41;United States;Northern America;Elsevier Inc.;1989, 2000-2022;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Physiology (Q2); Toxicology (Q2); Biochemistry (Q3); Cell Biology (Q3)"
154;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.751;Q2;62;56;122;2056;266;122;2.27;36.71;United States;Northern America;"John Wiley &amp; Sons Inc.";1998-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
155;29845;IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer;book series;10171606;0.742;Q2;48;0;23;0;78;23;2.24;0;France;Western Europe;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-2020;"Toxicology (Q2); Cancer Research (Q3)"
156;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;0.738;Q2;71;59;202;1845;406;172;1.65;31.27;Netherlands;Western Europe;Kluwer Academic Publishers;1987-2021;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
157;22318;Toxicological Reviews;journal;11762551;0.737;Q2;46;29;46;1862;103;45;2.24;64.21;United Kingdom;Western Europe;Adis International Ltd;2003-2006;"Pharmacology (Q2); Toxicology (Q2)"
158;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298, 14321912;0.726;Q2;93;94;441;3933;942;438;2.24;41.84;Germany;Western Europe;Springer Verlag;1969-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
159;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.722;Q2;66;40;121;1446;187;118;1.61;36.15;United States;Northern America;Academic Press Inc.;1971-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
160;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0.721;Q1;95;62;207;1960;489;196;1.89;31.61;United Kingdom;Western Europe;Informa Healthcare;1986-1987, 1992-2021;Pharmaceutical Science (Q1)
161;16088;Journal of Nanobiotechnology;journal;14773155;0.718;Q1;84;9;18;202;47;18;2.61;22.44;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Applied Microbiology and Biotechnology (Q2); Bioengineering (Q2); Biomedical Engineering (Q2); Molecular Medicine (Q3); Nanoscience and Nanotechnology (Q3)"
162;17067;Phytomedicine;journal;09447113, 1618095X;0.718;Q1;127;110;335;3126;699;322;1.97;28.42;Germany;Western Europe;Urban und Fischer Verlag Jena;1994-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
163;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.714;Q2;81;140;258;4925;582;258;2;35.18;Poland;Eastern Europe;Polish Physiological Society;1991-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2)"
164;5100155080;Neurotherapeutics;journal;19337213;0.712;Q2;122;58;51;5904;130;45;2.55;101.79;United States;Northern America;Springer New York;2007-2021;"Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
165;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.71;Q2;104;205;852;7362;1531;846;1.6;35.91;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
166;20083;British Journal of Clinical Pharmacology, Supplement;journal;02643774;0.706;Q1;32;0;27;0;109;25;3.56;0;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1998, 2000-2004;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
167;20602;Clinical Neuropharmacology;journal;1537162X, 03625664;0.703;Q2;80;71;191;2008;476;174;2.51;28.28;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1982-2021;"Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
168;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0.694;Q2;87;209;389;7290;754;381;1.94;34.88;Japan;Asiatic Region;Japanese Pharmacological Society;1996-2021;"Pharmacology (Q2); Molecular Medicine (Q3)"
169;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.691;Q2;79;79;212;2411;361;210;1.76;30.52;United Kingdom;Western Europe;Informa Healthcare;1985-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
170;17464;European Journal of Medicinal Chemistry;journal;02235234, 17683254;0.69;Q2;175;153;328;4740;767;327;2.29;30.98;France;Western Europe;Elsevier Masson s.r.l.;1974-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
171;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.689;Q2;47;29;83;1034;167;82;1.56;35.66;United States;Northern America;Begell House Inc.;1984-1990, 1992-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q2)"
172;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.688;Q2;107;177;526;6919;962;517;1.58;39.09;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q2); Physiology (medical) (Q2); Physiology (Q3)"
173;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.686;Q2;112;85;225;3322;447;208;1.88;39.08;United States;Northern America;Academic Press Inc.;1970, 1981-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
174;18966;Mutagenesis;journal;02678357, 14643804;0.684;Q2;95;59;225;2865;548;220;2.14;48.56;United Kingdom;Western Europe;Oxford University Press;1986-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Genetics (Q3); Genetics (clinical) (Q3)"
175;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.678;Q2;42;52;71;4786;125;65;1.9;92.04;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
176;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.673;Q2;74;68;218;1971;471;216;2.17;28.99;United States;Northern America;Wiley-Blackwell;1986-2021;"Medicine (miscellaneous) (Q1); Process Chemistry and Technology (Q1); Applied Microbiology and Biotechnology (Q2); Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Drug Discovery (Q2); Molecular Medicine (Q3)"
177;24785;Alcohol;journal;07418329;0.67;Q2;83;65;232;2842;541;224;1.83;43.72;United States;Northern America;Elsevier Inc.;1984-2021;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2); Behavioral Neuroscience (Q3); Biochemistry (Q3); Neurology (Q3)"
178;20027;BMC Pharmacology;journal;14712210;0.67;Q2;44;17;69;548;133;69;1.71;32.24;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
179;24604;Archives of Toxicology;journal;14320738, 03405761;0.667;Q2;121;88;297;3292;619;292;1.84;37.41;Germany;Western Europe;Springer Verlag;1930-1940, 1943-1944, 1972-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
180;16067;Reading Teacher;journal;00340561;0.662;Q2;53;68;250;1645;138;246;0.49;24.19;United States;Northern America;Wiley-Blackwell;1995-2021;"Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
181;25214;Toxicologic Pathology;journal;15331601, 01926233;0.661;Q2;112;99;335;3448;620;312;1.64;34.83;United States;Northern America;SAGE Publications Inc.;1972-2021;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
182;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785, 15578852;0.657;Q2;63;81;248;2110;427;238;1.67;26.05;United States;Northern America;Mary Ann Liebert Inc.;1996-2021;"Medicine (miscellaneous) (Q1); Oncology (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3)"
183;20051;BioDrugs;journal;11738804, 1179190X;0.649;Q2;71;35;137;3137;350;133;2.26;89.63;United Kingdom;Western Europe;Adis International Ltd;1997-2021;"Medicine (miscellaneous) (Q1); Biotechnology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
184;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.647;Q2;69;97;296;1840;563;280;1.92;18.97;Germany;Western Europe;Dustri-Verlag Dr. Karl Feistle;1994-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
185;20129;Cardiovascular Drug Reviews;journal;15273466, 08975957;0.646;Q2;50;24;74;1540;174;74;2.18;64.17;United States;Northern America;Neva Press, Inc.;1983-2007;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
186;25224;Toxicology in Vitro;journal;18793177, 08872333;0.644;Q2;112;118;301;4181;672;299;2.12;35.43;United Kingdom;Western Europe;Elsevier Ltd.;1987-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
187;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117, 1533869X;0.643;Q2;38;17;104;685;208;103;1.83;40.29;United States;Northern America;Old City Publishing;1996, 2002-2020;"Drug Discovery (Q2); Pharmacology (Q2); Cancer Research (Q3)"
188;16117;Pharmaceutical Biotechnology;journal;10780467;0.637;Q1;27;0;16;0;26;16;0;0;United States;Northern America;Kluwer/Plenum Publishers;1993, 1995-1999, 2002;"Pharmaceutical Science (Q1); Applied Microbiology and Biotechnology (Q2)"
189;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.632;Q2;58;106;164;2637;416;152;2.92;24.88;Italy;Western Europe;SAGE Publications Inc.;1989-2021;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
190;23942;Biomedical Chromatography;journal;10990801, 02693879;0.63;Q2;68;105;288;2176;396;286;1.31;20.72;United Kingdom;Western Europe;John Wiley and Sons Ltd;1986-2021;"Medicine (miscellaneous) (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
191;24028;Reproductive Toxicology;journal;08906238, 18731708;0.623;Q2;117;96;227;3865;548;215;2.03;40.26;United States;Northern America;Elsevier Inc.;1987-2021;Toxicology (Q2)
192;144771;Clinical Trials;journal;17407753, 17407745;0.621;Q2;67;71;60;1366;48;55;0.8;19.24;United Kingdom;Western Europe;SAGE Publications Ltd;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
193;25898;Journal of Peptide Science;journal;10752617, 10991387;0.615;Q2;68;99;217;3950;343;210;1.7;39.9;United Kingdom;Western Europe;John Wiley and Sons Ltd;1995-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Medicine (Q3); Structural Biology (Q3); Molecular Biology (Q4)"
194;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.614;Q2;87;130;440;6591;781;436;1.69;50.7;Canada;Northern America;National Research Council of Canada;1964-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (medical) (Q2); Physiology (Q3)"
195;29053;Molecular Diversity;journal;1573501X, 13811991;0.614;Q2;58;44;116;1545;203;111;1.75;35.11;Netherlands;Western Europe;Springer Netherlands;1995-1998, 2000, 2003-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Information Systems (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q4); Molecular Biology (Q4)"
196;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.611;Q2;40;38;53;4157;119;53;2.25;109.39;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Pharmacology (Q2)"
197;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.611;Q2;64;19;100;924;183;99;1.65;48.63;Netherlands;Western Europe;Springer Netherlands;1984-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
198;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.609;Q1;122;489;1139;13790;2008;1135;1.55;28.2;Japan;Asiatic Region;Pharmaceutical Society of Japan;1993-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
199;23412;Journal of AOAC International;journal;10603271;0.605;Q2;90;247;558;5656;811;552;1.25;22.9;United States;Northern America;AOAC International;1993-2021;"Food Science (Q1); Agronomy and Crop Science (Q2); Analytical Chemistry (Q2); Pharmacology (Q2); Environmental Chemistry (Q3)"
200;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.604;Q2;63;89;236;3158;477;211;1.8;35.48;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1960-1961, 1996-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
201;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.598;Q1;81;66;108;2025;264;103;2.54;30.68;Canada;Northern America;Canadian Society for Pharmaceutical Sciences;1998-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
202;21352;Expert Opinion on Pharmacotherapy;journal;17447666, 14656566;0.595;Q2;83;242;594;16676;1450;582;2.42;68.91;United Kingdom;Western Europe;Taylor and Francis Ltd.;1999-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
203;33349;Japanese Journal of Pharmacology;journal;13473506, 00215198;0.595;Q2;62;0;185;0;303;183;0;0;Japan;Asiatic Region;Japanese Pharmacological Society;1951-2002;Pharmacology (Q2)
204;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.594;Q2;90;60;180;1959;316;178;1.72;32.65;United States;Northern America;Springer New York;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Environmental Science (miscellaneous) (Q2); Mathematics (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3); Neuroscience (miscellaneous) (Q3)"
205;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427843, 17427835;0.589;Q2;93;147;312;5354;542;297;1.72;36.42;United States;Northern America;Wiley-Blackwell;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
206;21865;Fundamental and Clinical Pharmacology;journal;07673981, 14728206;0.586;Q2;77;77;213;3234;451;211;2.13;42;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1987-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
207;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.584;Q1;81;71;199;1557;321;198;1.48;21.93;United Kingdom;Western Europe;Informa Healthcare;1984-2021;"Pharmaceutical Science (Q1); Bioengineering (Q2); Colloid and Surface Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q3)"
208;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.584;Q2;62;76;202;3363;244;194;1.16;44.25;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1978-2021;"Pharmacology (Q2); Veterinary (miscellaneous) (Q2)"
209;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.583;Q2;64;40;66;1045;119;62;1.71;26.13;United States;Northern America;Springer New York;1996-1999, 2001-2021;Pharmacology (Q2)
210;24749;Addiction Biology;journal;13556215, 13691600;0.582;Q2;83;46;137;2142;271;128;1.9;46.57;United States;Northern America;Wiley-Blackwell;1996-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Psychiatry and Mental Health (Q2)"
211;130047;Current Drug Discovery Technologies;journal;15701638;0.581;Q2;44;22;24;1052;31;24;1.29;47.82;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Drug Discovery (Q2)
212;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.58;Q2;95;360;1005;7719;1417;1005;1.4;21.44;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-2021;"Medicine (miscellaneous) (Q1); Chemistry (miscellaneous) (Q2); Drug Discovery (Q2)"
213;25093;Environmental Toxicology;journal;15227278, 15204081;0.58;Q2;81;74;201;2657;390;197;1.69;35.91;United States;Northern America;"John Wiley &amp; Sons Inc.";1980, 1999-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Management, Monitoring, Policy and Law (Q2); Toxicology (Q2)"
214;4000148406;Clinical Toxicology;journal;15569519, 15563650;0.575;Q2;98;96;303;2296;614;249;1.76;23.92;United Kingdom;Western Europe;Informa Healthcare;1968-1998, 2005-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
215;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.57;Q2;51;53;88;6214;192;86;2.79;117.25;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
216;25864;Heterocycles;journal;03855414;0.57;Q2;66;316;1046;8518;1360;1038;1.35;26.96;Japan;Asiatic Region;Japan Institute of Heterocyclic Chemistry;1983-2021;"Analytical Chemistry (Q2); Pharmacology (Q2); Organic Chemistry (Q3)"
217;21229;Drug News and Perspectives;journal;02140934;0.568;Q2;51;83;239;3355;379;238;1.77;40.42;Spain;Western Europe;Prous Science;1990-2010;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
218;16533;Phytochemical Analysis;journal;09580344, 10991565;0.567;Q3;76;73;180;1327;265;180;1.27;18.18;United Kingdom;Western Europe;John Wiley and Sons Ltd;1990-2021;"Complementary and Alternative Medicine (Q1); Analytical Chemistry (Q2); Food Science (Q2); Medicine (miscellaneous) (Q2); Plant Science (Q2); Biochemistry (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
219;16573;Phytotherapy Research;journal;10991573, 0951418X;0.563;Q2;140;207;664;5560;1110;662;1.48;26.86;United Kingdom;Western Europe;John Wiley and Sons Ltd;1987-2021;Pharmacology (Q2)
220;29099;Cancer Chemotherapy and Pharmacology, Supplement;journal;09439404;0.562;Q2;33;0;53;0;87;53;4.43;0;Germany;Western Europe;Springer Verlag;1994, 1996-2003;"Oncology (Q2); Pharmacology (Q2); Cancer Research (Q3)"
221;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.559;Q2;90;108;354;2766;497;351;1.14;25.61;United States;Northern America;Informa Healthcare;1974, 1976-2021;"Pharmacology (Q2); Drug Discovery (Q3); Organic Chemistry (Q3)"
222;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.556;Q2;52;70;162;1150;146;157;0.91;16.43;United States;Northern America;Taylor and Francis Ltd.;1991-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q3)"
223;16803;Antiviral Chemistry and Chemotherapy;journal;20402066, 09563202;0.555;Q2;54;36;102;1871;190;101;2.01;51.97;United Kingdom;Western Europe;SAGE Publications Inc.;1991-2015, 2017-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Drug Discovery (Q3); Virology (Q3)"
224;20570;Chemotherapy;journal;00093157, 14219794;0.555;Q2;58;96;167;2812;308;160;1.68;29.29;Switzerland;Western Europe;S. Karger AG;1960-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Infectious Diseases (Q3); Oncology (Q3)"
225;14487;Journal of Ocular Pharmacology and Therapeutics;journal;15577732, 10807683;0.554;Q2;64;58;173;1688;207;172;1.14;29.1;United States;Northern America;Mary Ann Liebert Inc.;1987, 1991-1993, 1995-2021;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
226;19900192900;Molecular Informatics;journal;18681751, 18681743;0.551;Q3;70;86;183;2961;376;178;2;34.43;Germany;Western Europe;"Wiley - VCH Verlag GmbH &amp; CO. KGaA";2010-2021;"Computer Science Applications (Q2); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Structural Biology (Q4)"
227;21353;Expert Opinion on Therapeutic Patents;journal;13543776, 17447674;0.55;Q2;77;120;374;6911;539;361;1.36;57.59;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Drug Discovery (Q3)"
228;23489;Chemical Speciation and Bioavailability;journal;09542299;0.544;Q2;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1989-2018;"Chemical Health and Safety (Q1); Toxicology (Q2); Health, Toxicology and Mutagenesis (Q3)"
229;130126;Molecular Pharmaceutics;journal;15438384, 15438392;0.542;Q1;138;62;57;2124;128;53;2.25;34.26;United States;Northern America;American Chemical Society;2004-2021;"Pharmaceutical Science (Q1); Drug Discovery (Q3); Molecular Medicine (Q3)"
230;19443;American Journal of Health-System Pharmacy;journal;10792082, 15352900;0.538;Q2;99;425;1272;6317;1249;703;0.98;14.86;United States;Northern America;American Society of Health-Systems Pharmacy;1995-2021;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
231;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.534;Q2;78;44;155;1792;294;153;1.7;40.73;Switzerland;Western Europe;S. Karger AG;1988-1997, 2004-2021;"Dermatology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
232;23102;Journal of Pharmacy and Pharmacology;journal;20427158, 00223573;0.53;Q1;124;208;616;7287;1067;611;1.69;35.03;United Kingdom;Western Europe;Oxford University Press;1949-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
233;16319;IEEE Transactions on Nanobioscience;journal;15361241, 15582639;0.522;Q1;65;36;103;1821;200;100;1.98;50.58;United States;Northern America;Institute of Electrical and Electronics Engineers Inc.;2002-2021;"Pharmaceutical Science (Q1); Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Electrical and Electronic Engineering (Q2); Medicine (miscellaneous) (Q2); Bioengineering (Q3); Nanoscience and Nanotechnology (Q3)"
234;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.52;Q2;91;70;187;2604;349;178;1.88;37.2;United Kingdom;Western Europe;John Wiley and Sons Ltd;1981-2021;Toxicology (Q2)
235;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.518;Q3;50;37;135;1114;236;135;1.96;30.11;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2021;"Medicine (miscellaneous) (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
236;21256;Drugs of Today;journal;00257656, 16993993, 16994019;0.517;Q2;53;76;243;4444;465;242;1.96;58.47;Spain;Western Europe;Prous Science;1968, 1978-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
237;18077;Fitoterapia;journal;0367326X, 18736971;0.512;Q3;110;145;436;2071;581;435;1.1;14.28;Netherlands;Western Europe;Elsevier;1948-1949, 1961, 1972-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
238;22410;Inflammation Research;journal;1420908X, 10233830;0.511;Q3;94;118;436;3583;616;429;1.33;30.36;Switzerland;Western Europe;Birkhauser Verlag Basel;1995-2021;"Immunology (Q3); Pharmacology (Q3)"
239;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.51;Q2;65;73;200;1874;294;199;1.47;25.67;Germany;Western Europe;Wiley-VCH Verlag;1822-1831, 1835-1933, 1937-1938, 1940, 1943-1944, 1950-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
240;14822;Xenobiotica;journal;00498254, 13665928;0.506;Q3;82;77;252;2431;468;252;1.66;31.57;United Kingdom;Western Europe;Informa Healthcare;1971-2021;"Medicine (miscellaneous) (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
241;14990;Current Neuropharmacology;journal;18756190, 1570159X;0.505;Q3;82;23;32;3390;41;30;1.28;147.39;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;"Medicine (miscellaneous) (Q2); Neurology (clinical) (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2); Neurology (Q3); Pharmacology (Q3)"
242;25934;Cytokines, Cellular and Molecular Therapy;journal;14660830, 13684736;0.505;Q3;27;0;21;0;32;21;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2000, 2002;"Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
243;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.488;Q3;76;87;208;2151;331;197;1.5;24.72;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1976-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
244;4400151524;Particle and Fibre Toxicology;journal;17438977;0.487;Q3;105;11;3;752;3;2;1;68.36;United Kingdom;Western Europe;BioMed Central Ltd.;2004-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
245;23039;Journal of Liposome Research;journal;08982104, 15322394;0.478;Q2;53;15;73;852;121;70;1;56.8;United Kingdom;Western Europe;Informa Healthcare;1988-1990, 1992-2021;Pharmaceutical Science (Q2)
246;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.47;Q2;42;88;141;984;137;141;0.98;11.18;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
247;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0.468;Q3;98;221;693;6998;1004;692;1.53;31.67;United Kingdom;Western Europe;Nature Publishing Group;1980-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
248;13671;Biologicals;journal;10958320, 10451056;0.468;Q3;60;46;108;796;159;106;1.35;17.3;United States;Northern America;Academic Press Inc.;1990-2021;"Applied Microbiology and Biotechnology (Q2); Medicine (miscellaneous) (Q2); Bioengineering (Q3); Biotechnology (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Pharmacology (Q3)"
249;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.466;Q3;67;116;446;1249;419;416;0.93;10.77;United States;Northern America;American Pharmacists Association;2003-2021;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q3)"
250;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0.466;Q3;10;17;32;1065;22;14;0.69;62.65;United States;Northern America;Academic Press Inc.;2004-2005, 2008, 2012-2017, 2019;"Drug Discovery (Q3); Organic Chemistry (Q3)"
251;26370;Molecules;journal;14203049;0.458;Q2;171;159;304;4047;347;299;1.15;25.45;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);1992, 1996-2021;"Chemistry (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3); Molecular Medicine (Q4)"
252;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.455;Q2;63;97;175;1986;198;154;1.13;20.47;Netherlands;Western Europe;Springer Netherlands;2011-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3); Toxicology (Q3)"
253;21194;Pharmacology;journal;00317012, 14230313;0.453;Q3;60;87;269;2957;366;269;1.47;33.99;Switzerland;Western Europe;S. Karger AG;1959-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
254;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.445;Q2;51;233;657;5064;564;653;0.84;21.73;United States;Northern America;Taylor and Francis Ltd.;1996-2021;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3)"
255;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.443;Q2;62;55;135;1147;145;132;1.02;20.85;United States;Northern America;Informa Healthcare;1996-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
256;21100370879;"Journal of managed care &amp; specialty pharmacy";journal;23761032, 23760540;0.435;Q2;66;106;190;677;171;116;0.9;6.39;United States;Northern America;Academy of Managed Care Pharmacy (AMCP);2014-2021;"Pharmacy (Q1); Health Policy (Q2); Pharmaceutical Science (Q2)"
257;144956;Drug Metabolism and Pharmacokinetics;journal;13474367;0.434;Q2;69;57;169;945;239;169;1.52;16.58;Japan;Asiatic Region;Japanese Society for the Study of Xenobiotics;2002-2021;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
258;25106;Human and Experimental Toxicology;journal;09603271;0.428;Q3;82;88;298;2983;419;279;1.27;33.9;United States;Northern America;SAGE Publications Inc.;1981-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
259;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.428;Q3;75;71;104;2422;178;96;2.02;34.11;United States;Northern America;Elsevier Inc.;1992-2002, 2004-2021;"Pharmacology (Q3); Toxicology (Q3)"
260;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.419;Q3;41;50;83;6400;71;45;1.05;128;Netherlands;Western Europe;Elsevier;1995-1997, 2000-2003, 2005-2006, 2008, 2012-2021;"Drug Discovery (Q3); Organic Chemistry (Q3)"
261;4400151608;ChemMedChem;journal;18607187, 18607179;0.416;Q1;106;133;447;3338;614;446;1.1;25.1;United Kingdom;Western Europe;John Wiley and Sons Ltd;2006-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Organic Chemistry (Q3); Molecular Medicine (Q4)"
262;19374;AAPS PharmSciTech;journal;15309932;0.412;Q2;101;82;184;2226;213;172;1.09;27.15;Switzerland;Western Europe;Springer International Publishing AG;2000-2021;"Agronomy and Crop Science (Q2); Ecology (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Aquatic Science (Q3); Drug Discovery (Q3); Ecology, Evolution, Behavior and Systematics (Q3)"
263;27210;In Vivo;journal;17917549, 0258851X;0.41;Q3;64;157;300;5767;366;299;1.21;36.73;Greece;Western Europe;International Institute of Anticancer Research;1987-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
264;21825;Reviews in Contemporary Pharmacotherapy;journal;09548602;0.41;Q3;17;0;6;0;11;6;1;0;United Kingdom;Western Europe;Marius Press;1996-2004;Pharmacology (Q3)
265;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.405;Q3;88;177;178;6834;221;176;1.15;38.61;Netherlands;Western Europe;Elsevier;1996-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
266;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.403;Q2;61;51;136;1173;187;136;1.32;23;United Kingdom;Western Europe;John Wiley and Sons Ltd;1979-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
267;20770;Drug Delivery;journal;10717544, 15210464;0.403;Q2;72;46;118;1273;159;118;1.27;27.67;United Kingdom;Western Europe;Informa Healthcare;1993, 1995-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
268;21262;Drugs under Experimental and Clinical Research;journal;03786501;0.403;Q3;39;36;102;879;155;102;1.42;24.42;Switzerland;Western Europe;Bioscience Ediprint Inc.;1980-2005;"Pharmacology (medical) (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
269;29947;Journal of Chemotherapy;journal;1120009X, 19739478;0.401;Q3;52;115;399;3127;515;365;1.19;27.19;United Kingdom;Western Europe;Maney Publishing;1989-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
270;20634;Journal of Texture Studies;journal;00224901, 17454603;0.4;Q2;57;33;109;893;71;108;0.55;27.06;United States;Northern America;Wiley-Blackwell;1969-2021;"Food Science (Q2); Pharmaceutical Science (Q2)"
271;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X, 1414431X;0.391;Q1;91;227;648;7232;732;643;1.02;31.86;Brazil;Latin America;Associacao Brasileira de Divulgacao Cientifica;1973-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Cell Biology (Q4)"
272;21124;Pharmaceutical Statistics;journal;15391612, 15391604;0.391;Q3;39;31;32;410;19;28;0.59;13.23;United Kingdom;Western Europe;John Wiley and Sons Ltd;2004-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3); Statistics and Probability (Q4)"
273;4700152903;Forensic Toxicology;journal;18608965, 18608973;0.387;Q3;39;14;46;237;21;46;0.53;16.93;Japan;Asiatic Region;Springer Japan;2006-2021;"Biochemistry (medical) (Q2); Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
274;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.384;Q3;52;32;76;1740;115;72;1.51;54.38;United States;Northern America;Wiley-Liss Inc.;2003-2016;"Embryology (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3); Developmental Biology (Q4)"
275;20580;Journal of Food Biochemistry;journal;17454514, 01458884;0.383;Q3;50;43;98;1452;78;98;0.75;33.77;United States;Northern America;Wiley-Blackwell;1977-2021;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
276;130025;Current Drug Delivery;journal;15672018;0.377;Q2;65;45;38;3179;42;38;1.11;70.64;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Pharmaceutical Science (Q2)
277;130063;Pharmacological Reports;journal;17341140;0.374;Q3;87;127;324;5690;431;324;1.22;44.8;Netherlands;Western Europe;Elsevier BV;2005-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
278;84948;Expert Opinion on Drug Delivery;journal;17425247;0.372;Q2;116;81;16;7108;25;14;1.56;87.75;United Kingdom;Western Europe;Taylor and Francis Ltd.;2004-2021;Pharmaceutical Science (Q2)
279;94084;Drug Discovery Today: TARGETS;journal;17418372;0.371;Q3;15;0;171;0;115;142;0.71;0;Netherlands;Western Europe;Elsevier BV;2002-2004;Drug Discovery (Q3)
280;21717;Die Pharmazie;journal;00317144;0.369;Q2;66;212;675;4514;610;672;0.92;21.29;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-2021;Pharmaceutical Science (Q2)
281;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X, 15232859;0.369;Q3;20;66;188;569;140;188;0.88;8.62;United States;Northern America;Medical Letter Inc.;1965-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
282;19958;Archives of Pharmacal Research;journal;19763786, 02536269;0.367;Q3;93;223;549;5344;570;549;0.93;23.96;South Korea;Asiatic Region;Pharmaceutical Society of Korea;1978-2021;"Drug Discovery (Q3); Organic Chemistry (Q3); Molecular Medicine (Q4)"
283;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.366;Q3;76;336;940;5813;737;938;0.7;17.3;United States;Northern America;Springer New York;1966-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pollution (Q3); Toxicology (Q3)"
284;18800156720;Dissolution Technologies;journal;1521298X;0.361;Q2;34;32;53;186;29;26;0.56;5.81;United States;Northern America;Dissolution Technologies Inc;1996-2021;Pharmaceutical Science (Q2)
285;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.36;Q3;53;42;89;1332;110;88;0.95;31.71;Japan;Asiatic Region;Japanese Society of Toxicological Sciences;1976-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
286;12000154522;Advances in Antiviral Drug Design;book series;10758593;0.347;Q2;12;0;7;0;6;7;0.86;0;United Kingdom;Western Europe;Elsevier Ltd.;1996, 1999, 2003, 2007;"Pharmacology (medical) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Infectious Diseases (Q3); Virology (Q3)"
287;19441;American Journal of Drug Delivery;journal;11759038;0.344;Q3;22;21;20;2033;16;20;0.8;96.81;United Kingdom;Western Europe;Adis International Ltd;2004-2006;Pharmacology (Q3)
288;20578;Journal of Food and Drug Analysis;journal;10219498;0.343;Q3;63;59;150;1365;108;148;0.6;23.14;Taiwan;Asiatic Region;National Laboratories of Foods and Drugs;1994-2021;"Food Science (Q2); Pharmacology (Q3)"
289;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.341;Q3;48;99;326;1757;233;325;0.73;17.75;United Kingdom;Western Europe;John Wiley and Sons Ltd;1976-2021;"Analytical Chemistry (Q3); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q4)"
290;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.338;Q2;36;12;38;269;47;38;1.04;22.42;Germany;Western Europe;Walter de Gruyter GmbH;2015-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
291;20545;PDA Journal of Pharmaceutical Science and Technology;journal;19482124, 10797440;0.337;Q2;40;38;120;927;63;90;0.38;24.39;United States;Northern America;Parenteral Drug Association Inc.;1994-2021;Pharmaceutical Science (Q2)
292;21207;Drug Discovery Today: Technologies;journal;17406749;0.335;Q3;53;55;62;1688;68;61;1.1;30.69;United Kingdom;Western Europe;Elsevier Ltd.;2004-2021;"Biotechnology (Q3); Drug Discovery (Q3); Molecular Medicine (Q4)"
293;21192;Drug Development Research;journal;02724391, 10982299;0.334;Q3;62;80;323;5307;286;316;0.88;66.34;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;Drug Discovery (Q3)
294;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.333;Q3;62;79;190;3247;219;166;1.04;41.1;United States;Northern America;SAGE Publications Inc.;1982-2021;Toxicology (Q3)
295;22204;Journal of Drug Delivery Science and Technology;journal;17732247, 25888943;0.327;Q2;52;70;183;1834;120;182;0.67;26.2;France;Western Europe;Editions de Sante;2004-2021;Pharmaceutical Science (Q2)
296;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.325;Q3;64;48;292;1230;257;284;0.56;25.63;United States;Northern America;Heldref Publications;2005-2021;"Environmental Science (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
297;40278;Adverse Drug Reactions and Toxicological Reviews;journal;0964198X;0.324;Q3;24;0;19;0;36;19;0;0;United Kingdom;Western Europe;Adis International Ltd;1991-2002;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
298;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.322;Q3;24;23;24;2527;27;22;1.13;109.87;United Arab Emirates;Middle East;Bentham Science Publishers;2012-2021;"Infectious Diseases (Q3); Pharmacology (Q3)"
299;22435;International Journal of Clinical Pharmacology Research;journal;02511649;0.319;Q2;31;25;51;624;75;51;1.46;24.96;Switzerland;Western Europe;Bioscience Ediprint Inc.;1981-2005;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
300;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.31;Q3;38;29;138;1079;59;136;0.3;37.21;Netherlands;Western Europe;Springer Netherlands;1996-2002, 2005-2021;"Analytical Chemistry (Q3); Drug Discovery (Q3); Biochemistry (Q4); Bioengineering (Q4); Molecular Medicine (Q4)"
301;37697;Autonomic and Autacoid Pharmacology;journal;14748673, 14748665;0.301;Q3;21;22;83;782;72;82;0.75;35.55;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2002-2017;Pharmacology (Q3)
302;26767;Altex;journal;1868596X, 18688551;0.298;Q3;57;26;110;657;79;101;0.72;25.27;Germany;Western Europe;Springer International Publishing AG;2000-2021;"Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
303;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.298;Q3;46;37;90;1296;100;90;0.98;35.03;United States;Northern America;Informa Healthcare;1977-2021;"Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
304;21186;Drug Design and Discovery;journal;10559612, 10292322;0.291;Q3;20;0;16;0;18;16;1.42;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2003;"Drug Discovery (Q3); Molecular Medicine (Q4)"
305;21264;Drugs in R and D;journal;11796901, 11745886;0.285;Q3;47;49;230;1186;226;212;1.17;24.2;United Kingdom;Western Europe;Adis International Ltd;1999, 2002-2008, 2010-2021;Pharmacology (Q3)
306;21100470510;Drug Research;journal;21949379, 21949387;0.284;Q3;65;109;404;2303;371;402;0.84;21.13;Germany;Western Europe;Thieme;1972, 2013-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3)"
307;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699, 09750983;0.284;Q2;48;271;783;5318;420;783;0.52;19.62;India;Asiatic Region;Scientific Publishers of India;1970, 1973-1978, 1981, 1989-1991, 1996-2018, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q4)"
308;13248;Experimental and Toxicologic Pathology;journal;09402993, 16181433;0.282;Q3;70;59;162;2889;150;161;0.94;48.97;Germany;Western Europe;Urban und Fischer Verlag Jena;1992-2017;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Toxicology (Q3); Cell Biology (Q4)"
309;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.28;Q3;61;76;366;2953;316;339;0.69;38.86;United Kingdom;Western Europe;FRAME;1982, 1985-1986, 1988-1989, 1994-2021;"Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Toxicology (Q3)"
310;25144;Journal of Health Science;journal;13475207, 13449702;0.28;Q3;49;112;286;2572;229;286;0.71;22.96;Japan;Asiatic Region;Pharmaceutical Society of Japan;1999-2011;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
311;21265;Drugs of the Future;journal;03778282;0.278;Q3;45;612;797;5933;277;319;0.23;9.69;Spain;Western Europe;Prous Science;1978-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
312;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.278;Q3;53;78;215;1565;122;175;0.44;20.06;India;Asiatic Region;Association of Physiologists and Pharmacologists of India;1959-2021;"Pharmacology (Q3); Physiology (medical) (Q3); Physiology (Q4)"
313;22456;International Journal of Pharmacy Practice;journal;09617671, 20427174;0.278;Q2;39;34;101;977;66;100;0.47;28.74;United Kingdom;Western Europe;Oxford University Press;1991-2021;"Pharmacy (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Public Health, Environmental and Occupational Health (Q3)"
314;62892;Drug Discovery Today: BIOSILICO;journal;17418364;0.277;Q3;17;0;81;0;78;64;0.96;0;Netherlands;Western Europe;Elsevier BV;2003-2004;Drug Discovery (Q3)
315;20599;Paediatric and Perinatal Drug Therapy;journal;14630095;0.275;Q3;19;14;42;327;33;35;0.72;23.36;United Kingdom;Western Europe;Librapharm;1997-2008;"Pediatrics, Perinatology and Child Health (Q3); Pharmacology (Q3)"
316;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.274;Q2;57;35;126;806;101;123;0.73;23.03;United States;Northern America;Informa Healthcare;2013-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3)"
317;25171;Mycotoxin Research;journal;18671632, 01787888;0.273;Q3;40;65;116;634;53;115;0.7;9.75;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;1985-2021;"Biotechnology (Q3); Microbiology (Q3); Toxicology (Q3)"
318;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.271;Q2;72;141;362;3175;237;358;0.53;22.52;United Kingdom;Western Europe;Taylor and Francis Ltd.;1961-1972, 1975-2021;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
319;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.269;Q3;36;19;69;637;53;69;0.56;33.53;Germany;Western Europe;Walter de Gruyter GmbH;1985-1988, 1990-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Drug Discovery (Q4); Physiology (Q4)"
320;24578;Mathematical Medicine and Biology;journal;14778599;0.269;Q3;46;19;48;626;51;47;1.15;32.95;United Kingdom;Western Europe;Oxford University Press;1984-2021;"Medicine (miscellaneous) (Q2); Applied Mathematics (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Environmental Science (miscellaneous) (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Modeling and Simulation (Q3); Neuroscience (miscellaneous) (Q3); Pharmacology (Q3)"
321;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.268;Q2;69;98;302;1368;140;292;0.43;13.96;United States;Northern America;American Association of Colleges of Pharmacy;1945-1948, 1973-1989, 1991, 1996-2021;"Education (Q2); Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
322;20026;BMC Clinical Pharmacology;journal;14726904;0.266;Q3;39;6;18;137;27;18;1.7;22.83;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
323;73430;Pharmaceutical Technology;journal;15432521;0.265;Q2;38;216;447;849;106;301;0.23;3.93;United States;Northern America;Advanstar Communications Inc.;1979-1985, 1987, 1996-2021;"Pharmaceutical Science (Q2); Biophysics (Q3)"
324;16836;BMC Chemical Biology;journal;14726769;0.261;Q4;20;3;4;102;3;4;1;34;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Drug Discovery (Q4); Molecular Medicine (Q4)"
325;21211;Pharmacy Education;journal;14772701, 15602214;0.261;Q2;18;35;98;563;24;96;0.26;16.09;Netherlands;Western Europe;;1973-1978, 2002-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2); Education (Q3)"
326;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0.258;Q3;53;70;281;3500;278;280;1.02;50;Spain;Western Europe;Prous Science;1979-2010;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
327;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.254;Q3;53;52;151;1660;129;151;0.68;31.92;United Kingdom;Western Europe;Informa Healthcare;1978-2021;"Medicine (miscellaneous) (Q2); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3); Immunology (Q4)"
328;130089;Toxin Reviews;journal;15569543, 15569551;0.253;Q3;46;24;86;1359;64;77;0.74;56.63;United Kingdom;Western Europe;Informa Healthcare;1982-2021;Toxicology (Q3)
329;20065;BioPharm International;trade journal;1542166X, 19391862;0.251;Q2;29;167;346;876;78;298;0.22;5.25;United States;Northern America;Advanstar Communications Inc.;2002-2020;"Pharmaceutical Science (Q2); Biotechnology (Q3)"
330;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;21070180, 03787966;0.247;Q3;39;39;123;879;89;122;0.73;22.54;France;Western Europe;Springer Paris;1976-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
331;63982;Journal of Cannabis Therapeutics;journal;15299775, 15299783;0.247;Q3;16;0;38;0;36;33;1.17;0;United States;Northern America;Haworth Integrative Healing Press;2001-2004;Pharmacology (Q3)
332;4000148019;AAPS Journal;journal;15507416;0.24;Q2;118;83;194;4176;173;191;0.86;50.31;United States;Northern America;Springer New York;1999-2021;Pharmaceutical Science (Q2)
333;25253;Blutalkohol (discontinued);journal;00065250;0.24;Q3;13;39;77;514;23;73;0.29;13.18;Germany;Western Europe;Steintor-Verlag GmbH;1974-2017, 2020-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
334;24659;Comments on Toxicology;journal;08865140;0.236;Q3;12;0;39;0;18;33;0.42;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1995-2003;Toxicology (Q3)
335;19446;American Pharmaceutical Review;journal;10998012;0.233;Q2;24;95;237;910;97;214;0.34;9.58;United States;Northern America;Russell Publishing LLC;2002-2020;Pharmaceutical Science (Q2)
336;15340;Developments in Biologicals;journal;14246074, 16622960;0.231;Q3;38;122;225;2108;128;225;0.62;17.28;Switzerland;Western Europe;S. Karger AG;2000-2008, 2010, 2012-2013;"Pharmacology (Q3); Biomaterials (Q4); Immunology (Q4)"
337;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.23;Q2;45;73;277;1425;129;277;0.35;19.52;Poland;Eastern Europe;Polish Pharmaceutical Society;1951-1955, 1961-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
338;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.23;Q3;51;119;232;2870;108;225;0.38;24.12;India;Asiatic Region;Triveni Enterprises;1988-2021;"Environmental Engineering (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
339;24097;Journal of the Indian Chemical Society;journal;00194522;0.23;Q4;33;262;757;4652;261;748;0.32;17.76;India;Asiatic Region;Elsevier BV;1973-1985, 1987-1991, 1996-2021;"Inorganic Chemistry (Q3); Drug Discovery (Q4); Electrochemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
340;22411;Inflammopharmacology;journal;09254692, 15685608;0.229;Q3;55;56;111;1896;95;106;0.95;33.86;Switzerland;Western Europe;Birkhauser Verlag Basel;1991-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3); Immunology (Q4)"
341;20684;Current Pharmacogenomics;journal;15701603;0.224;Q3;12;24;32;2670;25;32;0.78;111.25;Netherlands;Western Europe;Bentham Science Publishers B.V.;2004-2007;"Pharmacology (Q3); Genetics (Q4)"
342;18384;Medicinal Chemistry Research;journal;10542523, 15548120;0.223;Q2;50;32;128;906;53;127;0.29;28.31;United States;Northern America;Birkhauser Boston;1994, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q4)"
343;13718;Pharmaceutical Engineering;journal;02738139;0.222;Q3;16;53;153;341;23;152;0.13;6.43;United States;Northern America;Int. Society for Pharmaceutical Engineering, Inc.;1996-2018;Pharmaceutical Science (Q3)
344;21102;Pharmaceutical Journal;journal;00316873;0.222;Q3;28;2553;7998;765;234;667;0.03;0.3;United Kingdom;Western Europe;Pharmaceutical Press;1945-1949, 1994-2012, 2014-2017;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
345;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.221;Q2;19;59;128;565;39;110;0.24;9.58;United States;Northern America;SAGE Publications Inc.;2000-2015, 2017-2018;"Marketing (Q2); Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Strategy and Management (Q3)"
346;19700185200;Journal of Natural Medicines;journal;13403443, 18610293;0.221;Q3;50;41;189;594;63;182;0.36;14.49;Germany;Western Europe;Springer Verlag;2006-2021;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q3); Drug Discovery (Q4); Organic Chemistry (Q4)"
347;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.219;Q3;23;12;14;427;11;12;0.73;35.58;United Kingdom;Western Europe;BioMed Central Ltd.;2002-2017;"Medicine (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
348;17700156431;Handbook of Analytical Separations;book series;15677192;0.215;Q3;12;0;29;0;14;1;0.48;0;Netherlands;Western Europe;Elsevier;2000-2001, 2003-2004, 2008, 2020;"Pathology and Forensic Medicine (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Analytical Chemistry (Q4); Environmental Chemistry (Q4)"
349;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.215;Q3;40;32;11;1348;9;10;0.82;42.13;United States;Northern America;Informa Healthcare;2004-2021;"Toxicology (Q3); Immunology (Q4)"
350;21496;Revista de Chimie (discontinued);journal;00347752;0.215;-;31;281;625;4270;175;624;0.3;15.2;Romania;Eastern Europe;Syscom 18 SRL;1973, 1996-2021;Chemistry (miscellaneous) (Q3)
351;12328;Current Therapeutic Research;journal;0011393X, 18790313;0.214;Q3;42;53;208;1419;135;190;0.68;26.77;United States;Northern America;Elsevier Inc.;1959-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
352;22854;Yakugaku Zasshi;journal;13475231, 00316903;0.214;Q3;43;100;311;3057;178;311;0.55;30.57;Japan;Asiatic Region;Pharmaceutical Society of Japan;1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
353;22881;Yaoxue Xuebao;journal;05134870;0.214;Q3;34;234;688;3043;242;686;0.34;13;China;Asiatic Region;Chinese Pharmaceutical Association;1960, 1962-1966, 1979-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Molecular Medicine (Q4)"
354;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.213;Q3;10;40;144;408;23;141;0.21;10.2;France;Western Europe;Editions de Sante;1991-2014, 2017-2018;Pharmaceutical Science (Q3)
355;22205;Saudi Pharmaceutical Journal;journal;13190164;0.211;Q3;57;23;76;927;16;73;0.24;40.3;Saudi Arabia;Middle East;King Saud University;1996-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
356;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.21;Q3;22;28;103;742;30;103;0.33;26.5;India;Asiatic Region;Informatics Publishing Limited;2002-2021;Pharmacology (Q3)
357;35190;Revista Espanola de Quimioterapia;journal;02143429;0.209;Q3;26;49;148;1328;59;131;0.47;27.1;Spain;Western Europe;Sociedad Espanola de Quiminoterapia;1989-2021;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
358;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.206;Q3;14;0;0;0;0;0;0;0;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2018;"Endocrinology, Diabetes and Metabolism (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
359;79053;Natural Product Sciences;journal;12263907;0.206;Q4;28;51;171;1045;61;171;0.33;20.49;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1997-2021;"Drug Discovery (Q4); Organic Chemistry (Q4)"
360;19427;Advances in Pharmacology;journal;15578925, 10543589;0.205;Q3;78;20;34;1519;10;32;0.29;75.95;United States;Northern America;Academic Press Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
361;19383;Fluoride - Quarterly Reports;journal;22534083, 00154725;0.205;Q4;48;43;89;853;69;81;0.72;19.84;New Zealand;Pacific Region;International Society for Fluoride Research;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q3); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3); Biochemistry (Q4); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
362;22906;Journal of China Pharmaceutical University;journal;10005048;0.205;Q3;14;136;425;1400;82;425;0.19;10.29;China;Asiatic Region;China Pharmaceutical University;1989-1991, 2002-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
363;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.204;Q3;19;116;351;2580;122;331;0.35;22.24;Japan;Asiatic Region;Japanese Pharmacological Society;1944, 1947-1948, 1951-1956, 1958-2021;Pharmacology (Q3)
364;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.204;Q3;19;247;659;1131;66;646;0.09;4.58;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1961, 1973-2019;Pharmaceutical Science (Q3)
365;25245;Veterinary and Human Toxicology;journal;01456296;0.204;Q4;41;0;331;0;201;317;0.61;0;United States;Northern America;Comparative Toxicology Laboratories;1977-2004;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4); Veterinary (miscellaneous) (Q4)"
366;22375;Indian Drugs;journal;0019462X;0.203;Q3;31;149;396;2172;79;393;0.15;14.58;India;Asiatic Region;Indian Drug Manufacturers' Association;1989-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
367;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0.201;Q3;29;55;74;2069;38;73;0.51;37.62;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Pharmacology (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
368;72164;Journal of Infectious Disease Pharmacotherapy;journal;10687777;0.201;Q3;6;0;24;0;5;24;0.21;0;United States;Northern America;Pharmaceutical Products Press;1996, 1998-1999, 2001-2004;"Microbiology (medical) (Q3); Pharmacology (Q3)"
369;110097;Food and Drug Law Journal;journal;1064590X;0.199;Q3;22;33;112;31;21;109;0.18;0.94;United States;Northern America;Food and Drug Law Institute;1992-2018, 2021;"Law (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3)"
370;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.199;Q3;66;32;99;886;68;99;0.66;27.69;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1979-2021;"Aging (Q3); Chemistry (miscellaneous) (Q3); Colloid and Surface Chemistry (Q3); Dermatology (Q3); Pharmaceutical Science (Q3); Drug Discovery (Q4)"
371;62531;Pharmaceutical News;journal;1071894X;0.199;Q3;11;0;66;0;26;57;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2002;Pharmaceutical Science (Q3)
372;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.198;Q4;62;31;82;1016;62;81;0.26;32.77;United Kingdom;Western Europe;SAGE Publications Ltd;1985-2021;"Public Health, Environmental and Occupational Health (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
373;73076;Drug Discovery World;journal;14694344;0.192;Q4;13;38;10;417;6;9;0.6;10.97;United Kingdom;Western Europe;RJ Communications and Media Ltd.;2004-2018;Drug Discovery (Q4)
374;144613;Journal of Generic Medicines (discontinued);journal;17411343;0.192;Q3;15;47;54;444;8;48;0.15;9.45;United Kingdom;Western Europe;SAGE Publications Inc.;2003-2015, 2017, 2021;Pharmaceutical Science (Q3)
375;21142;Pharmaceutisch Weekblad;journal;00316911;0.192;Q3;9;581;1431;831;59;1116;0.04;1.43;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);1948-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
376;22979;Journal of Applied Therapeutic Research;journal;10292659;0.191;Q3;8;10;37;192;10;37;0.27;19.2;United Kingdom;Western Europe;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q3)
377;23055;Journal of Natural Toxins;journal;10588108;0.191;Q4;26;0;44;0;35;44;0;0;United States;Northern America;Alaken Inc.;1996-2002;"Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
378;21083;Pharmaceutical Care Espana (discontinued);journal;11396202;0.191;Q3;9;21;139;252;14;120;0.05;12;Spain;Western Europe;Fundacion Pharamaceutical Care Espana;2001-2017;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
379;9500153932;Ciencia y Tecnologia Pharmaceutica;journal;15753409;0.188;Q3;6;26;78;459;9;66;0.1;17.65;Spain;Western Europe;Fundacion Alimentacion Saludable;1996-2007;Pharmacology (Q3)
380;23009;Journal of Clinical Research;journal;13695207;0.188;Q3;11;4;5;55;2;5;0.67;13.75;United Kingdom;Western Europe;PJB Publications Ltd.;1998-2009;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
381;17716;Quality Assurance Journal;journal;10991786, 10878378;0.188;Q3;9;34;92;189;7;80;0.08;5.56;United Kingdom;Western Europe;John Wiley and Sons Ltd;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
382;22357;IDrugs : the investigational drugs journal;journal;13697056, 20403410;0.187;Q3;35;206;616;1783;268;614;0.51;8.66;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
383;19700174971;Indian Journal of Forensic Medicine and Toxicology (discontinued);journal;09739122, 09739130;0.186;Q4;12;0;0;0;0;0;0;0;India;Asiatic Region;Institute of Medico-legal Publications;2008-2021;"Law (Q2); Health, Toxicology and Mutagenesis (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
384;4700152769;Pharmacopeial Forum (discontinued);journal;03634655;0.186;Q3;19;12;37;93;17;37;0.52;7.75;United States;Northern America;United States Pharmacopeial Convention Inc.;1996-1998, 2000-2018;"Drug Guides (Q2); Pharmacy (Q2); Pharmacology (Q3)"
385;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.185;Q3;62;102;279;2000;90;161;0.33;19.61;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-1980, 1982, 1984-1986, 1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
386;23171;Korean Journal of Pharmacognosy;journal;02533073;0.185;Q3;17;57;196;1197;32;196;0.16;21;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1990-2011, 2013-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
387;16698;Revista Brasileira de Plantas Medicinais;journal;1983084X, 15160572;0.182;Q3;29;58;86;1404;15;85;0.12;24.21;Brazil;Latin America;Instituto de Biociencias;1999-2016;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
388;21412;Zeitschrift fur Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.182;Q3;13;62;138;682;25;111;0.2;11;Germany;Western Europe;Hippokrates Verlag GmbH;1982, 1985-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
389;19398;Acta Pharmaceutica;journal;18469558, 13300075;0.18;Q3;60;41;101;1166;62;101;0.82;28.44;Croatia;Eastern Europe;Croatian Pharmaceutical Society;1986, 1992-2022;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (Q3)"
390;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.175;Q4;46;46;108;2359;67;106;0.67;51.28;United Kingdom;Western Europe;Informa Healthcare;1991-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
391;144790;Marine Drugs;journal;16603397;0.173;Q4;128;12;27;349;43;25;1.59;29.08;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2003-2021;Drug Discovery (Q4)
392;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.172;Q4;32;24;71;677;26;70;0.47;28.21;United Kingdom;Western Europe;Informa Healthcare;1982-2000, 2005-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
393;21795;Farmaceuticky Obzor (discontinued);journal;00148172;0.17;Q3;7;39;76;914;13;76;0.2;23.44;Slovakia;Eastern Europe;Postgraduate Medical and Pharmaceutical School;1961-1963, 1974, 1976-2016;Pharmaceutical Science (Q3)
394;21867;Geneesmiddelenbulletin;journal;03044629;0.17;Q3;7;75;203;193;16;34;0.08;2.57;Netherlands;Western Europe;Stichting Geneesmiddelenbulletin;1973-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
395;21227;Pharmacy in Practice;journal;13581538;0.17;Q4;5;85;134;515;13;111;0.12;6.06;United Kingdom;Western Europe;Medicom Publishing;1995-2009;"Health Policy (Q3); Pharmacology (medical) (Q3); Pharmacy (Q3); Pharmacology (Q4)"
396;21758;Prescrire International;journal;11677422;0.169;Q4;13;112;434;1134;119;199;0.27;10.13;France;Western Europe;Association Mieux Prescrire;1996-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
397;23284;Acta Physiologica et Pharmacologica Bulgarica;journal;03239950;0.168;Q4;15;0;12;0;7;12;0.58;0;Bulgaria;Eastern Europe;Universitetsko Izdatelstvo Sv. Kliment Okhridski/Publishing House of the Sofia University St. Kilment Ohridski;1974-1996, 1998-2001, 2003;"Pharmacology (Q4); Physiology (Q4)"
398;26653;Journal of Herbal Pharmacotherapy;journal;15229106, 15228940;0.167;Q4;29;25;87;711;31;76;0.22;28.44;United States;Northern America;The Haworth Herbal Press;2001-2008;"Biochemistry (Q4); Pharmacology (Q4)"
399;20564;Ceska a Slovenska Farmacie;journal;12107816;0.164;Q3;17;52;165;1262;49;164;0.31;24.27;Czech Republic;Eastern Europe;Czech Medical Association J.E. Purkyne;1994-2021;Pharmaceutical Science (Q3)
400;21127;Pharmaceutical Technology Europe;journal;01646826;0.162;Q3;18;123;209;321;23;127;0.1;2.61;United States;Northern America;Advanstar Communications Inc.;1998-2020;Pharmaceutical Science (Q3)
401;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.161;Q3;61;178;424;3248;116;424;0.29;18.25;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-2021;Pharmaceutical Science (Q3)
402;21811;Farmacia Hospitalaria;journal;21718695, 11306343;0.16;Q4;24;76;211;1729;79;167;0.44;22.75;Spain;Western Europe;Grupo Aula Medica S.A.;1990-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q4)"
403;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0.16;Q4;12;29;40;601;13;40;0.33;20.72;Japan;Asiatic Region;Medical and Pharmaceutical Society for WAKAN-YAKU;2004-2013;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
404;59665;Chinese Journal of Natural Medicines;journal;16723651;0.158;Q4;40;89;89;1112;20;89;0.22;12.49;China;Asiatic Region;China Pharmaceutical University;2004-2021;"Complementary and Alternative Medicine (Q3); Medicine (miscellaneous) (Q3); Drug Discovery (Q4)"
405;22338;Hospital Pharmacy;journal;19451253, 00185787;0.158;Q4;24;136;452;1641;77;382;0.18;12.07;United States;Northern America;Thomas Land Publishers Inc.;1973-2021;"Pharmacology (medical) (Q3); Pharmacy (Q3); Pharmacology (Q4)"
406;130031;Journal of Toxicologic Pathology;journal;09149198;0.158;Q4;30;24;74;747;19;74;0.22;31.13;Japan;Asiatic Region;Japanese Society of Toxicologic Pathology;1988-1990, 1992-2021;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
407;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.158;Q4;24;38;169;815;53;169;0.23;21.45;United States;Northern America;Western Pharmacology Society;1960-1969, 1973-2011;Pharmacology (Q4)
408;67938;Journal of Social and Administrative Pharmacy;journal;02810662;0.157;Q3;20;0;69;0;25;57;0.33;0;Sweden;Western Europe;Swedish Pharmaceutical Press;1962, 1986-2003;"Leadership and Management (Q2); Pharmaceutical Science (Q3)"
409;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0.156;Q4;27;81;65;3216;19;64;0.29;39.7;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q4); Molecular Medicine (Q4)"
410;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0.156;Q4;39;14;90;364;21;90;0.12;26;United States;Northern America;PJD Publications Ltd;1994-2007, 2009;"Medicine (miscellaneous) (Q3); Molecular Medicine (Q4); Pharmacology (Q4)"
411;24071;Metal-Based Drugs;journal;07930291, 16875486;0.155;Q4;38;0;12;0;6;12;0;0;United States;Northern America;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Drug Discovery (Q4); Inorganic Chemistry (Q4); Pharmacology (Q4); Toxicology (Q4)"
412;23074;Journal of Pharmaceutical Finance, Economics and Policy;journal;15385396, 15385698;0.153;Q3;7;17;40;450;9;36;0.23;26.47;United States;Northern America;Haworth Press Inc.;2003-2008;"Health Policy (Q3); Pharmaceutical Science (Q3); Pharmacology (Q4)"
413;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.151;Q3;46;17;93;406;27;92;0.27;23.88;Switzerland;Western Europe;MDPI AG;1949, 1960-1961, 1973-2021;Pharmaceutical Science (Q3)
414;21716;Pharmazeutische Zeitung;journal;00317136;0.15;Q4;7;440;1326;1290;23;677;0.02;2.93;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
415;20661;Current Drug Discovery;journal;14727463;0.146;Q4;12;0;401;0;74;233;0.22;0;United Kingdom;Western Europe;Current Drugs Ltd.;2002-2004;Pharmacology (Q4)
416;16893;Biogenic Amines;journal;15693910, 01688561;0.145;Q4;15;25;78;1104;29;75;0.38;44.16;Slovenia;Eastern Europe;Society of Integrated Sciences;1989-2007;"Neuroscience (miscellaneous) (Q4); Pharmacology (Q4)"
417;25197;Revista de Toxicologia (discontinued);journal;02127113;0.145;Q4;11;20;63;471;7;63;0.13;23.55;Spain;Western Europe;Asociacion Espanola de Toxicologia;1989-2017, 2020;Toxicology (Q4)
418;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.144;Q3;0;0;0;0;0;0;0;0;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
419;19978;Ars Pharmaceutica (discontinued);journal;00042927;0.144;Q3;20;29;41;638;15;39;0.37;22;Spain;Western Europe;Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017, 2021;"History and Philosophy of Science (Q3); Pharmaceutical Science (Q3)"
420;19700180822;Immunotoxicology of Drugs and Chemicals: an Experimental and Clinical Approach;book series;18739822;0.141;Q4;2;0;17;0;5;16;0.29;0;Netherlands;Western Europe;Elsevier;2004;"Immunology (Q4); Toxicology (Q4)"
421;15842;Journal of Applied Research;journal;1537064X;0.141;Q4;22;70;162;1973;49;162;0.3;28.19;United States;Northern America;The Journal of Applied Research;2001-2014;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
422;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.141;Q3;13;77;222;905;40;194;0.21;11.75;Germany;Western Europe;Wiley-VCH Verlag;1972-2012;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
423;69108;Chemotherapie Journal, Supplement;journal;09446486;0.14;Q4;6;0;12;0;2;11;0.33;0;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;1996-1997, 1999-2003;"Microbiology (medical) (Q4); Pharmacology (Q4)"
424;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.14;Q4;0;0;0;0;0;0;0;0;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1981-2016;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Clinical Psychology (Q4); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
425;72755;Phytomedica;journal;09723293;0.14;Q4;4;18;53;213;4;53;0.03;11.83;India;Asiatic Region;Society of Phytomedica;1999-2008;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
426;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185, 22312730;0.139;Q3;35;102;255;1278;3;218;0.01;12.53;India;Asiatic Region;Wolters Kluwer Medknow Publications;1996-1999, 2002-2021;"Anesthesiology and Pain Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
427;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.138;Q3;17;10;91;376;18;84;0.18;37.6;United States;Northern America;Informa Healthcare;1983-1990, 1992-2016;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
428;21077;Pharmaca;journal;00316857;0.138;Q4;5;11;21;286;9;21;0.42;26;Croatia;Eastern Europe;Udruzenje Organizacija Zdravstva Hrvatske;1989-2011;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
429;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.136;Q3;27;62;163;1009;45;158;0.26;16.27;France;Western Europe;Elsevier Masson s.r.l.;1945, 1947-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
430;15892;Journal of Drug Evaluation;journal;14791137;0.136;Q4;4;0;45;0;4;19;0.09;0;United Kingdom;Western Europe;Parthenon Publishing Group;2003-2004;"Pharmacy (Q3); Pharmacology (Q4)"
431;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.135;Q4;24;70;31;6427;13;28;0.42;91.81;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q3); Immunology (Q4); Immunology and Allergy (Q4); Pharmacology (Q4)"
432;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.134;Q4;20;23;85;465;14;84;0.1;20.22;Turkey;Middle East;Istanbul Medipol University;2006-2011, 2016-2021;Pharmaceutical Science (Q4)
433;22934;Chinese Pharmaceutical Journal;journal;10012494;0.134;Q4;21;535;996;5263;116;996;0.1;9.84;China;Asiatic Region;Chinese Pharmaceutical Association;1993-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
434;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.131;Q3;43;56;196;1867;40;185;0.12;33.34;Brazil;Latin America;Faculdade de Ciencias Farmaceuticas (Biblioteca-;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
435;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074, 09728066;0.13;Q4;11;9;47;166;5;34;0.13;18.44;India;Asiatic Region;Anil Aggrawal;2000-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
436;144963;Drug Discovery Today: Disease Models;journal;17406757;0.13;Q4;28;48;64;1909;8;64;0.13;39.77;United Kingdom;Western Europe;Elsevier Ltd.;2004-2020;"Drug Discovery (Q4); Molecular Medicine (Q4)"
437;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.129;Q4;29;12;121;284;28;120;0.23;23.67;United States;Northern America;Taylor and Francis Ltd.;1992-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
438;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.129;Q4;6;42;112;180;7;72;0.09;4.29;United States;Northern America;Russell Publishing LLC;2010-2018, 2021;"Health Policy (Q4); Pharmaceutical Science (Q4)"
439;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.129;Q4;18;36;72;1043;8;68;0.1;28.97;Brazil;Latin America;Universidade Estadual Paulista - UNESP;2005-2021;Pharmaceutical Science (Q4)
440;23107;Journal of Pharmacy Technology;journal;15494810, 87551225;0.127;Q4;13;46;136;791;15;97;0.11;17.2;United States;Northern America;SAGE Publications Inc.;1989-2021;Pharmaceutical Science (Q4)
441;19700180757;Advances in Phytomedicine;book series;1572557X;0.126;Q4;13;0;29;0;7;0;0;0;Netherlands;Western Europe;Elsevier;2002, 2006;"Drug Discovery (Q4); Plant Science (Q4)"
442;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115, 20082231;0.126;Q4;47;32;97;790;23;96;0.28;24.69;United Kingdom;Western Europe;BioMed Central Ltd.;2000-2021;"Medicine (miscellaneous) (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
443;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.125;Q4;18;25;51;796;4;49;0.08;31.84;Turkey;Middle East;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-2021;Pharmaceutical Science (Q4)
444;50105;Japanese Journal of Neuropsychopharmacology;journal;03887588, 13434144;0.125;Q4;11;34;86;1154;10;86;0.12;33.94;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1982-1997, 2002-2017;"Clinical Psychology (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
445;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.124;Q4;12;90;260;1283;25;258;0.1;14.26;China;Asiatic Region;Chinese Journal of Pharmacology and Toxicology;1986-2020;"Pharmacology (Q4); Toxicology (Q4)"
446;21798;Farmaceutski Glasnik;journal;00148202;0.124;Q4;6;15;58;355;4;58;0.07;23.67;Croatia;Eastern Europe;Hrvatsko Farmaceutsko Drustvo;1950-1951, 1962, 1990-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
447;15240;Iranian Journal of Medical Sciences;journal;17353688, 02530716;0.124;-;31;54;154;921;10;142;0.06;17.06;Iran;Middle East;Shiraz University of Medical Sciences;1979-1981, 1989-2021;Medicine (miscellaneous) (Q3)
448;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.123;Q4;9;35;49;578;2;49;0.06;16.51;Cuba;Latin America;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
449;4000148203;Handbook of Experimental Pharmacology;journal;01712004;0.122;Q4;96;155;1;17376;0;1;0;112.1;Germany;Western Europe;Springer Heidelberg;2004-2021;"Biochemistry (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
450;19700201521;Journal of Chemical and Pharmaceutical Research (discontinued);journal;09757384;0.122;Q4;39;0;1;0;0;1;0;0;India;Asiatic Region;JOCPR;2004, 2011-2016;Pharmaceutical Science (Q4)
451;91481;Pharmacology Reviews and Communications;journal;10288945;0.122;Q4;9;0;23;0;5;23;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2002;Pharmacology (Q4)
452;21814;Research Communications in Pharmacology and Toxicology;journal;10871101;0.122;Q4;7;0;24;0;6;24;0.14;0;United States;Northern America;PJD Publications Ltd;1997-2003;"Pharmacology (Q4); Toxicology (Q4)"
453;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.122;Q3;32;441;759;4499;100;759;0.11;10.2;China;Asiatic Region;Zhongguo Zhongyi Yanjiuyuan;1989-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Complementary and Alternative Medicine (Q4); Pharmacology (medical) (Q4)"
454;19700180737;Pharmacochemistry Library;journal;01657208;0.121;Q4;10;0;25;0;2;23;0;0;Netherlands;Western Europe;Elsevier;1995-1998, 2000, 2002;"Drug Discovery (Q4); Organic Chemistry (Q4); Pharmacology (Q4)"
455;19399;Acta Pharmaceutica Hungarica (discontinued);journal;00016659;0.12;Q4;14;23;88;696;11;88;0.12;30.26;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1965-2018;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q4)"
456;22887;Chinese Journal of Antibiotics;journal;10018689;0.119;Q4;11;198;494;1884;17;492;0.03;9.52;China;Asiatic Region;Editorial Office of Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
457;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.119;Q4;34;163;521;2680;44;518;0.08;16.44;United States;Northern America;Springer New York;1967-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
458;21800;Farmacevtski Vestnik (discontinued);journal;00148229;0.117;Q4;4;29;189;739;7;189;0.03;25.48;Slovenia;Eastern Europe;Slovenian Pharmaceutical Society;1961, 1989-2016;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
459;145693;Canadian Pharmacists Journal;journal;17151635;0.116;Q4;24;149;376;853;12;269;0.03;5.72;Canada;Northern America;Canadian Pharmacists Association;2005-2021;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
460;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.116;Q4;15;107;354;1619;42;354;0.13;15.13;Russian Federation;Eastern Europe;Izdatelstvo Meditsina;1992-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q4); Toxicology (Q4)"
461;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.115;Q4;37;37;78;1151;19;78;0.22;31.11;Croatia;Eastern Europe;Institute for Medical Research and Occupational Health;1953-2021;"Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
462;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.113;Q4;11;21;43;737;2;43;0.05;35.1;Turkey;Middle East;University of Ankara;1997-2001, 2003-2010, 2014, 2016-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
463;21932;Hindustan Antibiotics Bulletin;journal;00181935;0.113;Q4;9;9;18;0;2;18;0;0;India;Asiatic Region;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007, 2009;Pharmacology (Q4)
464;22908;Chinese Pharmacological Bulletin;journal;10011978;0.112;Q4;17;387;1000;5146;89;1000;0.08;13.3;China;Asiatic Region;Institute of Clinical Pharmacology;1993-2020;Pharmacology (Q4)
465;22977;Journal de Pharmacie de Belgique;journal;00472166;0.111;Q4;12;18;66;379;2;66;0.05;21.06;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
466;23173;Korean Journal of Physiology and Pharmacology;journal;20933827, 12264512;0.111;Q4;33;51;160;1736;10;160;0.07;34.04;South Korea;Asiatic Region;Korean Physiological Soc. and Korean Soc. of Pharmacology;1997-2021;"Pharmacology (Q4); Physiology (Q4)"
467;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;journal;18715125;0.111;Q4;21;23;19;1464;4;19;0;63.65;United States;Northern America;Academic Press Inc.;2001-2003, 2005, 2007-2021;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
468;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.111;Q4;9;29;106;463;5;87;0.04;15.97;Mexico;Latin America;Asociacion Farmaceutica Mexicana A.C.;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
469;19408;Actualites Pharmaceutiques;journal;05153700;0.11;Q4;5;184;412;261;1;303;0;1.42;Netherlands;Western Europe;Elsevier;1961, 1963, 1996-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
470;15680;Giornale di Neuropsicofarmacologia;journal;19711387, 03919048;0.11;Q4;1;27;95;386;1;84;0.02;14.3;Italy;Western Europe;CIC Edizioni Internazionali s.r.l.;1996-2008;"Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
471;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.11;Q4;16;62;301;1147;12;296;0.05;18.5;Japan;Asiatic Region;Life Science Publishing Co. Ltd;1981-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
472;22514;Japanese Journal of Chemotherapy;journal;13407007;0.109;Q4;12;93;235;1551;28;234;0.05;16.68;Japan;Asiatic Region;Japan Society of Chemotherapy;1995-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
473;19700188399;Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.];journal;19349254, 19349262;0.108;Q4;28;22;57;0;8;57;0.17;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
474;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;18828272, 03881601;0.108;Q4;7;49;160;625;4;133;0.03;12.76;Japan;Asiatic Region;Japanese Society of Clinical Pharmacology and Therapeutics;1970-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
475;19700189100;Pharmaceutical Medicine;journal;11782595, 11791993;0.108;Q4;19;43;81;829;8;59;0.08;19.28;United Kingdom;Western Europe;Adis International Ltd;2000-2001, 2008-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
476;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0.107;Q4;2;1;3;41;0;3;0;41;Japan;Asiatic Region;Shionogi Co. Ltd;1972-1974, 1987-2009, 2015;Pharmacology (Q4)
477;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.107;Q4;14;22;69;79;6;69;0.12;3.59;Japan;Asiatic Region;Nihon Sangyo Eisei Gakkai;1995-2021;"Medicine (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
478;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.106;Q4;3;95;301;316;9;224;0.01;3.33;United Kingdom;Western Europe;Samedan Ltd;2002-2016;Pharmaceutical Science (Q4)
479;21866;Gazi Universitesi Eczacilik Fakultesi Dergisi;journal;10159592;0.106;Q4;8;0;31;0;3;31;0.21;0;Turkey;Middle East;Gazi Universitesi;1984-2003;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
480;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.105;Q4;6;35;112;63;4;112;0.03;1.8;Spain;Western Europe;Real Academia de Farmacia;1949-2012, 2014;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
481;145096;Neuropsychopharmacologia Hungarica;journal;14198711;0.105;Q4;17;29;32;337;6;26;0.19;11.62;Hungary;Eastern Europe;Hungarian Association of Psychopharmacology;2004-2021;"Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
482;70864;Anales de la Real Academia Nacional de Farmacia (discontinued);journal;1697428X, 16974271;0.104;Q4;10;33;59;1045;4;57;0.08;31.67;Spain;Western Europe;Real Academia Nacional de Farmacia;1988-2018;"Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
483;19400157142;Chiang Mai University Journal of Natural Sciences;journal;16851994;0.104;-;12;0;5;0;1;5;0.2;0;Thailand;Asiatic Region;Chiang Mai University;2003, 2006, 2009-2021;Multidisciplinary (Q4)
484;21329;European Journal of Herbal Medicine;journal;13524755;0.104;Q4;2;0;14;0;0;6;0;0;United Kingdom;Western Europe;National Institute of Medical Herbalists Ltd;2001-2004;Pharmacology (Q4)
485;20543;Pharmacometrics;journal;03008533;0.104;Q4;6;0;76;0;4;76;0.07;0;Japan;Asiatic Region;Japanese Society of Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
486;89630;Psychopharmakotherapie, Supplement;journal;09465146;0.104;Q4;2;30;7;516;0;5;0;17.2;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;1997-1999, 2004-2005, 2007-2008;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
487;25196;Revista Brasileira de Toxicologia;journal;14152983;0.104;Q4;7;11;43;256;1;38;0.04;23.27;Brazil;Latin America;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
488;19407;Acta Poloniae Toxicologica;journal;12306967;0.103;Q4;4;0;18;0;3;18;0;0;Poland;Eastern Europe;Polskie Towarzystwo Toksykologiczne/Polish Society of Toxicology;1999-2002;Toxicology (Q4)
489;86688;Acta Toxicologica;journal;17316383;0.103;Q4;7;15;35;400;2;33;0.06;26.67;Poland;Eastern Europe;Nofer Institute of Occupational Medicine;2003-2007;Toxicology (Q4)
490;19430;Adverse Drug Reaction Bulletin;journal;21597774, 00446394;0.103;Q4;7;6;17;233;2;17;0;38.83;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1970, 1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
491;19982;Asia Pacific Journal of Pharmacology;journal;02179687;0.103;Q4;9;0;19;0;2;19;0.11;0;Singapore;Asiatic Region;Singapore University Press;1986-1998, 2000-2001, 2003-2004, 2006;Pharmacology (Q4)
492;19700175108;Drug Delivery System;journal;18812732, 09135006;0.103;Q4;8;49;96;681;3;96;0.03;13.9;Japan;Asiatic Region;Japan Society of Drug Delivery System;1986, 1988-2021;Pharmaceutical Science (Q4)
493;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.103;Q4;5;93;105;476;3;86;0.03;5.12;United Kingdom;Western Europe;Samedan Ltd;2004-2019;Pharmaceutical Science (Q4)
494;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.102;Q4;14;37;44;560;2;43;0.05;15.14;United Kingdom;Western Europe;Taylor and Francis Ltd.;1992, 2004-2013, 2015-2019;"Demography (Q4); Environmental Science (miscellaneous) (Q4); Toxicology (Q4)"
495;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X;0.102;Q4;10;0;0;0;0;0;0;0;Poland;Eastern Europe;Uniwersytet Medyczny w Lublinie;2012-2021;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
496;72763;Drugs Made in Germany;journal;00126683;0.102;Q4;4;0;13;0;0;13;0;0;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1964, 1973-2002;"Molecular Medicine (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
497;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.102;Q4;10;61;13;333;2;13;0;5.46;Netherlands;Western Europe;IOS Press BV;1999, 2001-2002, 2005, 2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
498;59522;Current Therapeutics;journal;0311905X;0.101;Q4;5;0;163;0;2;86;0;0;Australia;Pacific Region;ADIS Press;1974-1988, 1992, 1994, 1996-2002;Pharmacology (Q4)
499;21238;Drug Topics;journal;19378157, 00126616;0.101;Q4;8;485;1315;0;15;1228;0.01;0;United States;Northern America;Advanstar Communications Inc.;1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
500;3300147901;EMC - Toxicologie-Pathologie;journal;17625858;0.101;Q4;6;14;16;996;0;15;0;71.14;France;Western Europe;Editions scientifique et medicales Elsevier SAS;2004-2005;"Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
501;20778;EOS Rivista di Immunologia ed Immunofarmacologia;journal;03926699;0.101;Q4;5;0;25;0;0;25;0;0;Italy;Western Europe;Sigma-Tau SpA;1983-2001, 2003-2004;"Immunology (Q4); Pharmacology (Q4)"
502;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.101;Q4;9;14;34;231;1;30;0;16.5;India;Asiatic Region;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-2021;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
503;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.101;Q4;10;21;18;203;1;17;0.06;9.67;Netherlands;Western Europe;Brill Academic Publishers;1995, 1997, 2001, 2004-2006, 2008-2011, 2013-2021;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
504;80593;Journal of Medicinal Plants;journal;16840240;0.101;Q4;23;45;36;979;0;36;0;21.76;Iran;Middle East;;2004-2021;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
505;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;0.101;Q4;6;0;36;0;0;36;0;0;Nigeria;Africa;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009, 2015-2016;Pharmacology (Q4)
506;21823;Pharmacia;journal;04280296;0.101;Q4;16;73;35;936;2;35;0.08;12.82;Bulgaria;Eastern Europe;Pensoft Publishers;1945, 1954-1955, 1987-1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
507;19700180827;Progress in Pharmaceutical and Biomedical Analysis;book series;14643456;0.101;Q4;8;14;17;548;0;16;0;39.14;United Kingdom;Western Europe;Elsevier Ltd.;1994, 1996, 2000, 2003, 2005;"Biochemistry (Q4); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Biotechnology (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
508;20572;PZ Prisma;journal;09455566;0.101;Q4;5;32;99;577;5;86;0.06;18.03;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1994-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
509;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.101;Q4;14;9;22;142;1;22;0;15.78;Cuba;Latin America;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-2020;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
510;5800207507;Side Effects of Drugs Annual;book series;03786080;0.101;Q4;6;50;155;3354;3;155;0.03;67.08;Netherlands;Western Europe;Elsevier;1977-1995, 1997-2005, 2007-2012, 2014-2020;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
511;9500153934;Therapiewoche;journal;02566869;0.101;Q4;1;0;32;0;0;29;0;0;Austria;Western Europe;Therapiewoche Verlag;2000-2002;Pharmacology (Q4)
512;20628;Circular Farmaceutica;journal;00097314;0.1;Q4;3;52;99;244;3;87;0.04;4.69;Spain;Western Europe;Col-legi de Farmaceutics de la Provincia de Barcelona;1961, 1973-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
513;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.1;Q4;34;13;40;0;0;40;0;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
514;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.1;Q4;5;66;43;961;0;43;0;14.56;Bulgaria;Eastern Europe;PHARMAKON-Press;1989-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
515;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.1;Q4;3;12;40;207;0;38;0;17.25;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
516;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.1;Q4;5;13;48;282;1;48;0;21.69;Japan;Asiatic Region;Japanese Society of Oral Therapeutics and Pharmacology;1982-2021;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
517;58808;Pharmaceutical Care and Research;journal;16712838;0.1;Q4;8;103;116;803;1;113;0.01;7.8;China;Asiatic Region;Publishing House of Pharmaceutical Care and Research;2004-2021;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
518;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790, 21684804;0.1;Q4;46;78;358;1505;120;343;0.31;19.29;United States;Northern America;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4)"
519;4100151606;Actualites Pharmaceutiques Hospitalieres;journal;17697344;;-;3;37;0;328;0;0;0;8.86;France;Western Europe;Elsevier Masson s.r.l.;2005-2012;Pharmaceutical Science
520;130150;Advances in Pharmacy;journal;15323862;;-;2;25;0;660;0;0;0;26.4;United States;Northern America;Facts and Comparisons;2005;Pharmaceutical Science
521;145689;Alimentary Pharmacology and Therapeutics Symposium Series;journal;17466334;;-;9;8;0;127;0;0;0;15.88;United Kingdom;Western Europe;;2005-2007;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
522;5100152606;Biosciences Biotechnology Research Asia (discontinued);journal;09731245;;-;18;92;0;1493;0;0;0;16.23;India;Asiatic Region;Oriental Scientific Publishing Company;2005-2016;"Agronomy and Crop Science; Biotechnology; Drug Discovery"
523;4000151703;Core Evidence (discontinued);journal;15551741, 1555175X;;-;25;12;0;708;0;0;0;59;New Zealand;Pacific Region;Dove Medical Press Ltd.;2005-2018;"Medicine (miscellaneous); Pharmacology; Reviews and References (medical)"
524;25466;Current Medicinal Chemistry: Immunology, Endocrine and Metabolic Agents;journal;15680134;;-;10;64;36;5982;12;32;0.33;93.47;Netherlands;Western Europe;Bentham Science Publishers B.V.;2004-2005;"Endocrinology, Diabetes and Metabolism; Immunology and Allergy; Pharmacology"
525;130007;Drug Design Reviews Online;journal;15672697;;-;10;48;0;5344;0;0;0;111.33;Netherlands;Western Europe;Bentham Science Publishers B.V.;2005;"Drug Discovery; Molecular Medicine; Pharmaceutical Science"
526;144718;Enhancer - Biotherapy of Cancer;journal;15720004;;-;0;28;0;348;0;0;0;12.43;Netherlands;Western Europe;;2005-2006;"Cancer Research; Drug Discovery; Immunology; Immunology and Allergy; Oncology"
527;21100938253;Environmental Pollutants and Bioavailability;journal;26395940, 26395932;;-;33;16;41;501;43;40;1.29;31.31;United Kingdom;Western Europe;Taylor and Francis Ltd.;2019-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
528;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;;-;88;51;0;5082;0;0;0;99.65;United Kingdom;Western Europe;Taylor and Francis Ltd.;2005-2021;"Medicine (miscellaneous); Pharmacology; Toxicology"
529;4400151410;Human Vaccines;journal;15548600, 15548619;;-;58;39;0;651;0;0;0;16.69;United States;Northern America;Landes Bioscience;2005-2011;"Immunology; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
530;130072;International Journal of Medicinal Mushrooms;journal;15219437;;-;33;37;0;1540;0;0;0;41.62;United States;Northern America;Begell House Inc.;2005-2021;"Applied Microbiology and Biotechnology; Drug Discovery; Pharmacology"
531;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;;-;48;36;106;876;16;99;0.14;24.33;Iran;Middle East;Iranian Journal of Pharmaceutical Research;2002-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
532;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;;-;33;26;0;979;0;0;0;37.65;Spain;Western Europe;Elsevier Espana;2005-2021;"Agricultural and Biological Sciences (miscellaneous); Biochemistry, Genetics and Molecular Biology (miscellaneous); Medicine (miscellaneous); Neuroscience (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
533;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;;-;25;13;0;339;0;0;0;26.08;Singapore;Asiatic Region;Elsevier;2005-2021;"Pharmaceutical Science; Pharmacology (nursing); Sports Science"
534;27767;Journal of Forensic Medicine and Toxicology;journal;09711929;;-;18;19;56;199;14;54;0.18;10.47;India;Asiatic Region;;1997-2020;"Pathology and Forensic Medicine; Toxicology"
535;15323;Journal of Jilin University Medicine Edition;journal;1671587X;;-;7;243;0;1853;0;0;0;7.63;China;Asiatic Region;Jilin University Press;2005-2021;Pharmacology
536;10300153342;Journal of Medical Toxicology;journal;15569039, 19376995;;-;52;8;0;0;0;0;0;0;United States;Northern America;Springer New York;2005-2021;"Health, Toxicology and Mutagenesis; Toxicology"
537;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;;-;9;11;0;167;0;0;0;15.18;Turkey;Middle East;University of Istanbul;2005, 2007-2008, 2010, 2012, 2015-2016;"Pharmaceutical Science; Pharmacy"
538;3500148011;Journal of Zhejiang University: Science B;journal;16731581;;-;61;53;0;62;0;0;0;1.17;China;Asiatic Region;Zhejiang University Press;2005-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Medicine (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Veterinary (miscellaneous)"
539;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;26;93;189;2296;38;189;0.17;24.69;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-2021;"Drug Discovery; Pharmaceutical Science"
540;130038;Letters in Drug Design and Discovery;journal;15701808;;-;35;99;0;4122;0;0;0;41.64;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;"Drug Discovery; Molecular Medicine; Pharmaceutical Science"
541;4700152603;Medicinal Chemistry;journal;15734064, 18756638;;-;46;63;0;1362;0;0;0;21.62;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;Drug Discovery
542;130006;Medicinal Chemistry Reviews - Online;journal;15672034;;-;7;46;0;5102;0;0;0;110.91;Netherlands;Western Europe;Bentham Science Publishers B.V.;2005;"Drug Discovery; Molecular Medicine"
543;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;;-;133;48;0;1539;0;0;0;32.06;United States;Northern America;Elsevier Inc.;2005-2021;"Bioengineering; Biomedical Engineering; Materials Science (miscellaneous); Medicine (miscellaneous); Molecular Medicine; Nanoscience and Nanotechnology; Pharmaceutical Science"
544;21100862294;Neuropsychopharmacology Reports;journal;2574173X;;-;14;1;36;0;8;34;0;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2018-2021;"Clinical Psychology; Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
545;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;;-;42;53;0;95;0;0;0;1.79;Pakistan;Asiatic Region;Pakistan Journal of Pharmaceutical Sciences;1995, 2005-2021;Pharmaceutical Science
546;130170;Phytotherapie;journal;17652847, 16248597;;-;18;57;0;651;0;0;0;11.42;France;Western Europe;Springer Paris;2005-2020;"Complementary and Alternative Medicine; Pharmacology"
547;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;;-;54;36;0;1507;0;0;0;41.86;United States;Northern America;Elsevier Inc.;2005-2021;"Pharmaceutical Science; Pharmacy"
548;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;;-;47;2;0;72;0;0;0;36;India;Asiatic Region;A and V Publication;1997, 2005, 2011-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
549;4700151615;Scandinavian Journal of Work, Environment and Health, Supplement;journal;03566528;;-;23;18;0;161;0;0;0;8.94;Finland;Western Europe;Finnish Institute of Occupational Health;2005-2011, 2016-2018;"Geography, Planning and Development; Health, Toxicology and Mutagenesis; Public Health, Environmental and Occupational Health; Toxicology"
550;145000;Signal;journal;14719967;;-;1;22;0;327;0;0;0;14.86;United Kingdom;Western Europe;Adis International Ltd;2005-2007;"Drug Discovery; Oncology; Pharmacology (medical)"
551;144879;Toxicology International;journal;09716580;;-;28;20;0;322;0;0;0;16.1;India;Asiatic Region;Society of Toxicology India;2005-2021;"Health, Toxicology and Mutagenesis; Toxicology"
